{"gene":"MFN2","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2003,"finding":"Mfn1 and Mfn2 are both required for mitochondrial fusion in mammalian cells; loss of either causes severe mitochondrial fragmentation. Mfn1 and Mfn2 form homotypic (Mfn1-Mfn1, Mfn2-Mfn2) and heterotypic (Mfn1-Mfn2) complexes, and homotypic complexes are functional for fusion. A subset of mitochondria in mutant cells lose membrane potential, indicating that fusion has a protective role.","method":"Mfn1 and Mfn2 knockout mouse embryonic fibroblasts, mitochondrial morphology imaging, genetic rescue, co-immunoprecipitation to detect homotypic and heterotypic complexes","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, KO MEF rescue experiments, multiple orthogonal methods, widely replicated foundational study","pmids":["12527753"],"is_preprint":false},{"year":2013,"finding":"Mfn2 physically interacts with PERK at the ER and acts as an upstream repressor of PERK kinase activity. Mfn2-ablated cells show sustained basal PERK activation; PERK silencing in Mfn2-null cells reduces ROS production, normalizes mitochondrial calcium, and improves mitochondrial morphology.","method":"Co-immunoprecipitation to detect Mfn2-PERK interaction; siRNA knockdown of Mfn2, PERK, and XBP-1 in MEFs with ER stress induction; measurement of ROS, mitochondrial calcium, and morphology","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, multiple genetic knockdowns, multiple functional readouts, single lab","pmids":["23921556"],"is_preprint":false},{"year":2016,"finding":"Mfn2 deficiency in skeletal muscle reduces autophagy and impairs mitochondrial quality. Aging-induced Mfn2 decrease triggers a ROS-dependent adaptive signaling pathway via HIF1α and BNIP3 to compensate for lost mitophagy and minimize mitochondrial damage.","method":"Skeletal muscle-specific Mfn2 knockout mice; gene expression profiling, mitophagy/autophagy assays, ROS and HIF1α/BNIP3 measurements","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO mouse model, multiple orthogonal functional readouts, single lab","pmids":["27334614"],"is_preprint":false},{"year":2018,"finding":"MFN2 fusion activity is regulated by an intramolecular interaction between Met376/His380 and Asp725/Leu727; PINK1 kinase phosphorylates adjacent Ser378, controlling this interaction. Small-molecule mimics of this peptide-peptide interface allosterically activate MFN2 and promote mitochondrial fusion, overcoming dominant CMT2A-mutant MFN2-induced mitochondrial defects.","method":"Mutagenesis of MFN2 interaction residues; PINK1 kinase phosphorylation assays; small-molecule agonist treatment in cultured neurons and CMT2A mouse model; assessment of mitochondrial trafficking, morphology, membrane potential","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis of catalytic/interface residues, in vitro kinase assay, in vivo mouse model, multiple orthogonal functional readouts","pmids":["29674596"],"is_preprint":false},{"year":2017,"finding":"Mfn2 directly interacts with perilipin 1 in brown adipose tissue, facilitating physical and functional contacts between mitochondria and lipid droplets in response to adrenergic stimulation. Mfn2, but not Mfn1, deficiency in BAT leads to impaired respiratory capacity and blunted adrenergic response.","method":"Adipose-specific Mfn2 knockout mice; Co-immunoprecipitation of Mfn2-perilipin 1; confocal imaging of mitochondria-lipid droplet contacts; respiratory capacity measurements","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — tissue-specific KO, Co-IP, live-cell imaging, multiple functional readouts, single lab","pmids":["28348166"],"is_preprint":false},{"year":2020,"finding":"AMPK directly interacts with MFN2 and translocates to the MAM and mitochondria under energy stress. MFN2 (but not MFN1) is required for energy stress-induced autophagy and MAM formation; re-expression of MFN2 in Mfn2-null MEFs rescues autophagy defects.","method":"Co-immunoprecipitation of AMPK-MFN2; Mfn2-knockout and Mfn2-null rescue MEFs; MAM quantification by electron microscopy; oxygen consumption rate and glycolysis measurements","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct Co-IP, genetic KO with rescue, electron microscopy, multiple functional readouts, single lab","pmids":["32249716"],"is_preprint":false},{"year":2023,"finding":"MFN2 physically interacts with SERCA2 (ER-embedded Ca2+-ATPase) at mitochondria-ER contact sites in CD8+ T cells, enhancing ER-mitochondria tethering and facilitating mitochondrial Ca2+ influx for efficient mitochondrial metabolism. MFN2 also stimulates SERCA2 ER Ca2+ retrieval activity, preventing excessive mitochondrial Ca2+ accumulation and apoptosis.","method":"Genetic ablation of Mfn2 in CD8+ T cells; Co-immunoprecipitation of MFN2-SERCA2; Ca2+ flux measurements; mitochondrial metabolic assays; tumor immunotherapy models","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, conditional KO, multiple Ca2+ and metabolic assays, in vivo tumor model, single lab","pmids":["37738362"],"is_preprint":false},{"year":2022,"finding":"MFN2 drives mitochondria to cluster and tether onto the nuclear envelope via MFN2-enriched contact points. Mitochondrial PDC (pyruvate dehydrogenase complex) crosses the nuclear envelope through a non-canonical pathway (independent of nuclear pore complexes) at these MFN2-dependent tethering sites, interacting with lamin A; reduced nuclear MFN2 decreases mitochondria tethering and nuclear PDC levels.","method":"Live imaging and super-resolution microscopy of mitochondria-nuclear envelope contacts; nuclear fractionation; pharmacological NPC blockade; Co-immunoprecipitation of PDC-lamin A; siRNA knockdown of MFN2","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — reconstitution-style fractionation, Co-IP, pharmacological and genetic perturbation, multiple orthogonal methods, single lab","pmids":["35245450"],"is_preprint":false},{"year":2021,"finding":"Mfn2 localization to the ER (not mitochondria) is required for its bioenergetic function. ER-located Mfn2 interacts with mitochondrial Mfn1/2 to tether ER and mitochondria, enabling Ca2+ transfer from ER to mitochondria, which enhances mitochondrial metabolism. This ER-localized function is also necessary for proper neuritic outgrowth.","method":"ER-targeted vs. mitochondria-targeted Mfn2 constructs in Mfn2 KO neurons; Co-immunoprecipitation; Ca2+ transfer assays; mitochondrial bioenergetics measurements; neurite outgrowth assays; artificial ER-mitochondria tether rescue","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — targeted constructs, Co-IP, Ca2+ assays, genetic KO with organelle-specific rescue, multiple readouts, single lab","pmids":["34296790"],"is_preprint":false},{"year":2021,"finding":"In vivo Mfn2 conditional knockout in hippocampal and cortical pyramidal neurons reduces ER-mitochondria close contacts and decreases mitochondrial Ca2+ uptake and IP3R3-Grp75 interaction. Mfn2 overexpression increases ER-mitochondria contacts and the VAPB-PTPIP51 tethering pair interaction, supporting Mfn2 as a positive regulator of ER-mitochondrial tethering in vivo.","method":"Mfn2 conditional KO and overexpression mice; electron microscopy for ultrastructural quantification of ER-mitochondria contacts; biochemical fractionation; Co-immunoprecipitation of IP3R3-Grp75 and VAPB-PTPIP51","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo conditional KO and OE, electron microscopy, Co-IP, multiple contact-site markers, single lab","pmids":["34110411"],"is_preprint":false},{"year":2023,"finding":"PGAM5 phosphatase interacts with MFN2 in a stress-sensitive manner and dephosphorylates MFN2 to protect it from ubiquitination and degradation, thereby promoting mitochondrial fusion. Phosphorylation of MFN2 enhances fission and degradation, while dephosphorylation enhances fusion. Drosophila genetic epistasis places Marf (MFN2 ortholog) and dPGAM5 in the same biological pathway.","method":"Co-immunoprecipitation of PGAM5-MFN2; phosphorylation and ubiquitination assays; mitochondrial morphology imaging; Drosophila genetic epistasis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, biochemical phosphorylation/ubiquitination assays, genetic epistasis in Drosophila, single lab with multiple orthogonal methods","pmids":["37498743"],"is_preprint":false},{"year":2016,"finding":"Drosophila Clu promotes VCP/p97-dependent Marf (MFN2 ortholog) degradation in the context of Parkin-mediated mitophagy; Clu binds VCP in vivo, and overexpression of Clu destabilizes Marf in vitro. This degradation step is required for progression of mitophagy.","method":"Drosophila genetic epistasis (clu, PINK1, parkin mutants); in vivo Co-IP of Clu-VCP; in vitro Marf degradation assay; confocal imaging of mitochondrial clearance","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo Co-IP, in vitro degradation assay, genetic epistasis, but Drosophila ortholog only","pmids":["26931463"],"is_preprint":false},{"year":2018,"finding":"Parkin-dependent ubiquitination of Mfn2 at a specific site is required for ER-mitochondria tethering. In Parkin-deficient cells and patient fibroblasts, ER-mitochondria tethering is decreased. A non-ubiquitinatable Mfn2 mutant fails to restore ER-mitochondria physical and functional interaction.","method":"Co-immunoprecipitation; Parkin-deficient cells and parkin mutant human fibroblasts; non-ubiquitinatable Mfn2 mutant rescue experiments; Drosophila PD model behavioral rescue with synthetic ER-mitochondria linker","journal":"Pharmacological research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — mutagenesis of ubiquitination site, patient fibroblasts, Co-IP, in vivo Drosophila rescue, multiple orthogonal methods","pmids":["30219582"],"is_preprint":false},{"year":2017,"finding":"MFN2 suppresses mTORC2/Akt signaling by directly interacting with mTORC2 through its HR1 domain. MFN2 knockout in cancer cells elevates mTORC2 activity and promotes AktS473 phosphorylation-mediated cancer growth and metastasis.","method":"CRISPR/Cas9 MFN2 knockout in MCF7 and A549 cells; Co-immunoprecipitation of MFN2-mTORC2; domain mapping (HR1 fragment); xenograft tumor model; signaling analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP with domain mapping, genetic KO, in vivo xenograft, single lab","pmids":["28176801"],"is_preprint":false},{"year":2013,"finding":"Endogenous Mfn2 inhibits cell proliferation by acting as an effector of Ras, inhibiting the Ras-Raf-ERK signaling pathway. The N-terminal fragment (aa 1-264) interacts with Raf-1, while the C-terminal fragment (aa 265-757) interacts with Ras to inhibit proliferation through distinct mechanisms.","method":"Mfn2 knockdown in BJAB cells and Mfn2 KO MEFs; reintroduction of Mfn2 fragments; Co-immunoprecipitation of N-term Mfn2 with Raf-1 and C-term Mfn2 with Ras; proliferation assays","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP with domain fragments, KO MEFs, genetic rescue, single lab","pmids":["24081906"],"is_preprint":false},{"year":2014,"finding":"Mfn2 physically contacts melanosomes through fibrillar bridges in pigment cells, and Mfn2 knockdown significantly reduces mitochondria-melanosome connections. Mfn2 loss prevents OA1-stimulated melanogenesis, linking Mfn2-dependent contacts to secretory organelle biogenesis.","method":"Electron tomography of mitochondria-melanosome contacts; Mfn2 knockdown; immunolocalization of Mfn2 at contact sites; melanogenesis assays","journal":"Current biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electron tomography, genetic knockdown with functional readout, single lab","pmids":["24485836"],"is_preprint":false},{"year":2022,"finding":"MFN2 physically interacts with PFK1 (phosphofructokinase 1) through its C-terminus, promoting PFK1 ubiquitin-proteasome dependent degradation by facilitating the association between PFK1 and E3 ligase TRIM21. MFN2 downregulation by mechanical stretch stabilizes PFK1, shifts metabolism toward glycolysis, and promotes VSMC proliferation/migration.","method":"Co-immunoprecipitation, pull-down, surface plasmon resonance, mutagenesis of MFN2 C-terminus; metabolomics; VSMC stretch model; vein graft mouse model","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — reciprocal Co-IP, pull-down, SPR biophysical binding, mutagenesis, metabolomics, in vivo model, single lab","pmids":["35450439"],"is_preprint":false},{"year":2021,"finding":"VCP cofactor UBXN1 facilitates MFN2 removal from the outer mitochondrial membrane during PRKN-dependent mitophagy. Loss of UBXN1 impairs MFN2 extraction, leading to accumulation of para-mitochondrial MFN2 blobs and impaired PRKN translocation to depolarized mitochondria.","method":"UBXN1 knockout cells; Co-immunoprecipitation of UBXN1-PRKN (UBX domain dependent); mitochondrial fractionation; mitophagy flux assays; confocal and super-resolution imaging of MFN2 blobs","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, genetic KO, fractionation, mitophagy assays, single lab","pmids":["33966597"],"is_preprint":false},{"year":2021,"finding":"Vps13D functions upstream of Marf/MFN2 in a conserved pathway regulating mitochondria-ER contact sites; vps13d mutants accumulate elevated Marf/MFN2 levels, and loss of marf/MFN2 suppresses vps13d mutant phenotypes including enlarged mitochondria-ER contacts and autophagy defects.","method":"Drosophila genetic epistasis (vmp1, vps13d, marf double/triple mutants); human cell VPS13D knockdown and MFN2 rescue; electron microscopy; autophagy assays","journal":"Current biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in Drosophila and human cells, electron microscopy, single lab","pmids":["34019822"],"is_preprint":false},{"year":2022,"finding":"MFN1 and MFN2 promote clustering between mitochondria and peroxisomes; MFNs are enriched at the mitochondria-peroxisome interface, and a truncated MFN2 lacking the transmembrane region inhibits peroxisome-mitochondria tethering.","method":"Proximity labeling (BioID) with peroxisomal proteins; overexpression of MFNs; confocal microscopy of co-clustering; dominant-negative truncated MFN2 expression","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — proximity labeling, overexpression/dominant-negative, imaging, single lab","pmids":["35523862"],"is_preprint":false},{"year":2022,"finding":"MFN2-stabilized MAMs increase in lifetime and stability during ER stress. MFN2 knockdown blunts mitochondrial Ca2+ uptake during ER stress, switches mitochondrial F1FO-ATPase into reverse mode, and strongly reduces ATP supply to the ER during ER stress.","method":"Structured illumination super-resolution microscopy of MAMs; MFN2 knockdown; mitochondrial Ca2+ measurements; OXPHOS and ATP assays during ER stress induction","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — super-resolution imaging, genetic knockdown, Ca2+ and bioenergetic assays, single lab","pmids":["36158213"],"is_preprint":false},{"year":2022,"finding":"In Drosophila, MARF (MFN2 ortholog) knockdown in heart tubes increases mitochondrial heterogeneity and induces cardiomyopathy, rescued by human MFN1 or MFN2, demonstrating functional homology. Reactive oxygen species mediate the cardiomyopathy in mitochondrial fusion-defective cardiomyocytes; SOD1 expression prevents the phenotype.","method":"Drosophila heart tube-specific RNAi of MARF; live imaging; human MFN1/MFN2 rescue; transgenic SOD1 overexpression; cardiomyocyte morphometric analysis","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Drosophila genetic model, cross-species rescue establishing functional homology, live imaging, single lab","pmids":["21148429"],"is_preprint":false},{"year":2014,"finding":"In excitotoxicity, Mfn2 expression is downregulated via MEF2 transcription factor degradation. Mfn2 reduction causes mitochondrial dysfunction, altered calcium homeostasis, enhanced Bax translocation to mitochondria, and delayed neuronal death. MEF2 regulates basal Mfn2 expression in neurons.","method":"In vitro and in vivo excitotoxicity models; siRNA knockdown of Mfn2; MEF2 knockdown and overexpression; measurement of MEF2 binding to Mfn2 promoter; mitochondrial membrane potential and Bax translocation assays","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockdown, promoter binding assay, multiple functional readouts, in vivo and in vitro, single lab","pmids":["25147362"],"is_preprint":false},{"year":2020,"finding":"Mfn2 physically interacts with PERK in podocytes; high-glucose conditions decrease Mfn2-PERK interaction, and Mfn2 silencing activates the PERK pathway, causing MAM reduction, mitochondrial dysfunction, and increased apoptosis. Mfn2 overexpression inhibits PERK activation and is anti-apoptotic, and PERK inhibition does not affect Mfn2 levels, placing Mfn2 upstream of PERK.","method":"Co-immunoprecipitation of Mfn2-PERK; Mfn2 siRNA knockdown and overexpression in podocytes; PERK inhibitor treatment; mitochondrial morphology and MAM quantification; apoptosis assays","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP, genetic KO/OE, epistasis by inhibitor, multiple functional readouts, single lab","pmids":["34988075"],"is_preprint":false},{"year":2022,"finding":"The CMT2A-associated MFN2 mutant R364W causes mitochondrial hyperfusion due to enhanced DRP1 ubiquitylation and proteasomal degradation by MITOL/MARCHF5. MITOL preferentially ubiquitylates wild-type MFN2 over R364W-MFN2, making the ligase more available for DRP1 multi-monoubiquitylation and degradation.","method":"Co-immunoprecipitation of MITOL with WT vs. R364W MFN2; ubiquitylation assays; proteasome inhibitor treatment; DRP1 degradation assays; mitochondrial morphology imaging","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP comparison, ubiquitylation assay, pharmacological inhibition, single lab","pmids":["34870686"],"is_preprint":false},{"year":2023,"finding":"LRRK2 kinase phosphorylates MFN2 at Ser27 via LRRK2-MKK4/JNK signaling, promoting ubiquitination-mediated MFN2 degradation and subsequent mitochondrial fragmentation in renal tubular cells. Lrrk2-knockout mice show MFN2 accumulation and reduced AKI severity.","method":"LRRK2 overexpression and Lrrk2 knockout mouse model; phospho-MFN2-Ser27 detection; Co-IP; JNK pathway inhibitor studies; mitochondrial morphology and ROS measurements","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphorylation site identification, KO mouse, Co-IP, in vivo functional readout, single lab","pmids":["37633049"],"is_preprint":false},{"year":2023,"finding":"Mfn2 interacts with MFN1 in testes and with nuage-associated proteins (MIWI, DDX4, TDRKH, GASZ); MFN2 also interacts with MSY2 in polysome fractions to regulate translation of gamete-specific mRNAs such as Spata19 during spermatogenesis. MFN2 conditional knockout in postnatal germ cells causes male sterility.","method":"Co-immunoprecipitation of MFN2 with nuage proteins and MSY2; polysome fractionation; conditional Mfn2 KO in postnatal germ cells; Mfn1/Mfn2 double KO; translational activity assays","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with multiple partners, polysome fractionation, conditional KO, single lab","pmids":["33674260"],"is_preprint":false},{"year":2021,"finding":"Mfn2 ablation specifically in spermatogonia causes DNA oxidation and apoptosis in differentiating spermatogonia and spermatocytes, causing male infertility. MFN2 regulates spermatogenesis by modulating both mitochondrial and ER functions, a distinct mechanism from MFN1; MFN2 defects are rescued only by MFN2 targeted to either organelle, not by MFN1.","method":"Mfn2 conditional KO in germ cells; Mfn1 conditional KO; organelle-targeted Mfn2 rescue constructs; DNA oxidation and apoptosis assays","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO, organelle-targeted rescue, multiple readouts, single lab","pmids":["32330448"],"is_preprint":false},{"year":2024,"finding":"MFN2 recruits α-tubulin acetyltransferase 1 (ATAT1) to sites of mitochondria-microtubule contact, promoting local α-tubulin acetylation. This activity is required for MFN2-dependent regulation of mitochondrial transport. CMT2A-associated MFN2 mutations R94W and T105M cannot properly release ATAT1 at these contact sites, linking this function to axonal degeneration.","method":"Live imaging of mitochondria-microtubule contacts; Co-immunoprecipitation of MFN2-ATAT1; MFN2 KO and CMT2A mutant expression; measurement of α-tubulin acetylation and mitochondrial motility in neurons","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, KO, disease mutant comparison, live imaging, single lab","pmids":["38883841"],"is_preprint":false},{"year":2024,"finding":"Mfn2 forms a complex with Hsc70 at mitochondria-lipid droplet contact (MLC) sites; mitochondrion-localized Mfn2 interacts with LD-localized Hsc70, tethering mitochondria to lipid droplets and facilitating fatty acid transfer from LDs to mitochondria for β-oxidation. Prolonged lipid overload induces MFN2 acetylation at K243 and subsequent ubiquitin-proteasome degradation.","method":"Co-immunoprecipitation of Mfn2-Hsc70; electron microscopy of MLC sites; Mfn2 knockdown and overexpression; fatty acid transfer assays; acetylation site mapping; in vivo lipid overload model","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, EM, functional transfer assay, PTM mapping, in vivo model, single lab","pmids":["38311582"],"is_preprint":false},{"year":2020,"finding":"Defective Mfn2 variants associated with CMT2A (near HB1-HB2 hinge) show reduced GTP-dependent oligomerization in cis and impaired membrane fusion in vitro; addition of cytosolic extract or soluble Bax improves both nucleotide-dependent assembly and fusion, suggesting cytosolic factors can compensate for molecular defects of CMT2A variants.","method":"In vitro membrane fusion assay with reconstituted proteoliposomes; nucleotide-dependent assembly assays; addition of purified Bax or cytosol extract; Mfn2-null cell rescue for morphology","journal":"Life science alliance","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro fusion assay, GTP assembly assay, defined variant mutagenesis, biochemical rescue","pmids":["32245838"],"is_preprint":false},{"year":2023,"finding":"E3 ubiquitin ligase RBCK1 interacts with and polyubiquitylates MFN2, promoting its proteasomal degradation under ferroptotic stress in pancreatic cancer cells, leading to decreased mitochondrial ROS production and lipid peroxidation, thereby conferring ferroptosis resistance.","method":"Co-immunoprecipitation of RBCK1-MFN2; ubiquitylation assays; RBCK1 knockdown/depletion; xenograft mouse model; ROS and lipid peroxidation measurements","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP, ubiquitylation assay, genetic KO, in vivo xenograft, single lab","pmids":["38763208"],"is_preprint":false},{"year":2022,"finding":"MFN2 physically interacts with Rab21 (in its GTP-loaded form); through this EGFR-Rab21-MFN2 axis, endocytosed EGFR is docked to mitochondria and dephosphorylated by OMM-resident phosphatase PTPRJ, suppressing EGFR signaling and ccRCC progression.","method":"Bio-layer interferometry and Co-immunoprecipitation of MFN2-Rab21; Co-IP of EGFR-Rab21-MFN2; mass spectrometry; kidney-specific Mfn2 knockout mouse model; xenograft assays","journal":"Cancer communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — BLI biophysical binding, Co-IP, tissue-specific KO mouse, single lab","pmids":["37378422"],"is_preprint":false},{"year":2023,"finding":"Mfn2 downregulation in microglia causes mitochondrial fusion-fission imbalance, triggering release of mitochondrial DNA into the cytoplasm, which activates the cGAS-STING signaling pathway and aggravates neuroinflammation after spinal cord injury.","method":"Microglial Sting knockout mouse model; Mfn2 siRNA knockdown in microglia; cytosolic mtDNA quantification; cGAS-STING pathway activation assays (TBK1, IRF3 phosphorylation); nanoparticle delivery of MFN2 agonist","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO, siRNA, pathway activation assays, in vivo SCI model, single lab","pmids":["38009491"],"is_preprint":false},{"year":2019,"finding":"E2F1 transcription factor directly binds the MFN2 promoter and increases endogenous MFN2 expression; E2F1 and SP1 form a complex on the MFN2 promoter during S-phase. E2F1-driven MFN2 expression modulates mitochondrial fusion and mitophagy.","method":"E2F1 overexpression; chromatin immunoprecipitation (ChIP) for E2F1 and SP1 on MFN2 promoter; Co-IP of E2F1-SP1; MFN2 mRNA and protein measurement; mitophagy and mitochondrial morphology assays","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — ChIP, Co-IP of transcription complex, overexpression, functional mitochondrial readouts, single lab","pmids":["31276298"],"is_preprint":false},{"year":2023,"finding":"Mfn2 physically interacts with IP3R3 in pulmonary arterial smooth muscle cells; this interaction mediates mitochondrial Ca2+ transport via MAMs. Mfn2 overexpression reduces IP3R3 expression, decreases excessive mitochondrial Ca2+ transport, and restores mitochondrial integrity, suppressing PASMCs proliferation.","method":"Co-immunoprecipitation of Mfn2-IP3R3; Mfn2 overexpression and silencing; IP3R3 inhibition; mitochondrial Ca2+ measurements; MCT-induced PAH rat model","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP, genetic OE/KD, Ca2+ assays, in vivo rat model, single lab","pmids":["40128893"],"is_preprint":false},{"year":2021,"finding":"USP2 (deubiquitinating enzyme) interacts with MFN2 and stabilizes it through deubiquitination, thereby preventing mitochondrial dysfunction in cardiac hypertrophy. MFN2 knockdown neutralizes the protective effect of USP2 overexpression.","method":"Co-immunoprecipitation of USP2-MFN2; deubiquitination assay; USP2 overexpression and MFN2 siRNA rescue experiments; in vitro and in vivo cardiac hypertrophy models","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP, deubiquitination assay, rescue experiment, in vivo model, single lab","pmids":["37100191"],"is_preprint":false},{"year":2024,"finding":"MORN4 directly binds MFN2 and promotes phosphorylation of MFN2-S442 through ROCK2 kinase, mediating beneficial mitophagy through mitochondrial dynamics. SPC promotes the MORN4-MFN2 interaction.","method":"Co-immunoprecipitation of MORN4-MFN2; phospho-MFN2-S442 measurement; ROCK2 kinase assays; MORN4 knockdown mouse MI model; confocal mitophagy assays","journal":"Free radical biology & medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Co-IP, phosphorylation assay, single lab, single study","pmids":["36682578"],"is_preprint":false},{"year":2020,"finding":"Mul1 E3 ubiquitin ligase binds MFN2 and promotes its ubiquitination and degradation in the context of cerebral ischemia/reperfusion injury; ginsenoside CK reduces the Mul1-MFN2 binding affinity, thereby preserving MFN2 protein levels and mitochondrial dynamics.","method":"Co-immunoprecipitation of Mul1-Mfn2; ubiquitination assay; pharmacological reduction of Mul1-Mfn2 affinity; in vitro OGD/reperfusion and in vivo MCAO/reperfusion models","journal":"Journal of ginseng research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Co-IP, ubiquitination assay, single lab, single study","pmids":["37252276"],"is_preprint":false},{"year":2022,"finding":"MFN2 stabilizes mitochondria-ER contact sites; the R364W-MFN2 CMT2A mutant alters ER-mitochondria association at MAM junctions, predisposes mitochondria to rapid fission upon mild stress, and perturbs inter-organellar calcium homeostasis.","method":"Confocal and proximity ligation assays for MAM contacts; mitochondrial Ca2+ and ER Ca2+ measurements; stress-induced fission assays in cells expressing WT vs. R364W-MFN2","journal":"Biology of the cell","confidence":"Low","confidence_rationale":"Tier 3 / Weak — overexpression of disease mutant, proximity assays, Ca2+ measurements, single lab, single study","pmids":["35924634"],"is_preprint":false},{"year":2024,"finding":"Endogenous MFN2 interactome (identified by CRISPR-Cas9 HA-tagging) includes RAB5C (endosomal modulator of mitochondrial homeostasis) and SLC27A2 (fatty acid transporter, relevant to autophagy) as novel validated partners, in addition to known ER and mitochondrial partners, with interactors regulated by nutrient deprivation.","method":"CRISPR-Cas9 endogenous HA-tagging of MFN2; HA affinity isolation followed by mass spectrometry; validation of RAB5C and SLC27A2 interactions; functional follow-up for autophagy","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — endogenous tagging, mass spectrometry-based interactome with functional validation of specific partners, single lab","pmids":["39675054"],"is_preprint":false},{"year":2011,"finding":"A MFN2 missense mutation (D210V) causes multiple mitochondrial DNA deletions in skeletal muscle, establishing that impaired mitochondrial fusion due to MFN2 dysfunction leads to inability to repair stress-induced mitochondrial DNA damage, and that MFN2 is required for mtDNA stability.","method":"Genetic identification of MFN2 D210V mutation; detection of multiple mtDNA deletions in patient skeletal muscle; fibroblast mitochondrial network fragmentation and respiratory chain deficiency; mtDNA damage repair assay","journal":"Brain : a journal of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient-derived fibroblasts, mtDNA repair functional assay, clinical genetics, single family study","pmids":["22189565"],"is_preprint":false},{"year":2020,"finding":"Mfn2 overexpression promotes ROS-dependent PINK1/Parkin-pathway mitophagy in nucleus pulposus cells, and Mfn2 overexpression protects against oxidative stress-induced autophagic flux impairment, mitochondrial dysfunction, and apoptosis. Autophagy inhibition blocks these protective effects.","method":"Mfn2 KD and OE in rat nucleus pulposus cells; PINK1/Parkin pathway assays; autophagic flux assays; chloroquine inhibition; adenoviral Mfn2 injection in rodent disc degeneration model","journal":"Osteoarthritis and cartilage","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, OE/KD with pharmacological inhibition, pathway inference without direct reconstitution","pmids":["31926268"],"is_preprint":false},{"year":2022,"finding":"Rab26 interacts with MFN2 and affects MFN2 transport to mitochondria; Rab26 deficiency reduces MFN2 levels in mitochondria, decreasing mitochondrial ROS and ATP production and impairing macrophage phagocytosis.","method":"Co-immunoprecipitation of Rab26-MFN2; Rab26 knockout macrophages; MFN2 mitochondrial localization assay; MFN2 siRNA; phagocytosis and ROS/ATP measurements; in vivo Rab26 KO ARDS model","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP, genetic KO, subcellular fractionation, functional readouts, in vivo model, single lab","pmids":["37060270"],"is_preprint":false}],"current_model":"MFN2 is a dynamin-like GTPase anchored in the outer mitochondrial membrane and ER that promotes mitochondrial fusion through GTP-dependent oligomerization, tethers the ER to mitochondria via trans-interactions with mitochondrial Mfn1/2 to enable Ca2+ transfer and bioenergetic coupling, forms regulated contacts with lipid droplets (via Hsc70), melanosomes, peroxisomes, and the nuclear envelope (to facilitate PDC nuclear import), restrains PERK kinase activity, suppresses Ras-Raf-ERK and mTORC2/Akt signaling, recruits ATAT1 to microtubule contact sites to regulate α-tubulin acetylation and mitochondrial transport, and is itself controlled by PINK1-mediated phosphorylation (Ser378), PGAM5 dephosphorylation, Parkin/MITOL/RBCK1/LRRK2-driven ubiquitination, and USP2/USP30 deubiquitination, with its activity and stability tuned by these post-translational modifications to coordinate mitochondrial dynamics, quality control, calcium homeostasis, and metabolic signaling."},"narrative":{"mechanistic_narrative":"MFN2 is a dynamin-like GTPase that drives mitochondrial fusion and serves as a master organizer of inter-organelle contact sites, coordinating mitochondrial dynamics, calcium homeostasis, quality control, and metabolic signaling [PMID:12527753, PMID:34296790]. Together with its paralog MFN1, it is required for mammalian mitochondrial fusion, forming functional homotypic and heterotypic complexes whose loss causes fragmentation and membrane-potential collapse [PMID:12527753]; fusion proceeds through GTP-dependent cis-oligomerization gated by an intramolecular interaction (Met376/His380–Asp725/Leu727) that is controlled by PINK1 phosphorylation of adjacent Ser378, and that can be pharmacologically activated to rescue CMT2A-mutant defects [PMID:29674596, PMID:32245838]. A distinct ER-localized pool of MFN2 tethers ER to mitochondria by trans-interaction with mitochondrial MFN1/2, enabling ER-to-mitochondria Ca2+ transfer that supports bioenergetics and neuritic outgrowth, acting through contact-site machinery including IP3R3-Grp75 and VAPB-PTPIP51 and engaging SERCA2 to balance Ca2+ flux [PMID:34296790, PMID:34110411, PMID:37738362]. Beyond classical MAMs, MFN2 nucleates contacts with lipid droplets via Hsc70 for fatty-acid transfer, with melanosomes, peroxisomes, and the nuclear envelope, where it tethers mitochondria to enable non-canonical nuclear import of the pyruvate dehydrogenase complex [PMID:38311582, PMID:24485836, PMID:35523862, PMID:35245450]. MFN2 also functions as a signaling brake, repressing PERK kinase activity at the ER, suppressing Ras-Raf-ERK and mTORC2/Akt pathways through domain-specific interactions, and recruiting ATAT1 to mitochondria-microtubule contacts to regulate α-tubulin acetylation and mitochondrial transport [PMID:23921556, PMID:24081906, PMID:28176801, PMID:38883841]. MFN2 abundance and fusion activity are tightly set by post-translational control: PGAM5 dephosphorylation protects it from degradation, while phosphorylation by PINK1 and LRRK2 and ubiquitination by Parkin, MITOL, RBCK1, and Mul1 (reversed by USP2) couple MFN2 to mitophagy and stress responses [PMID:37498743, PMID:37633049, PMID:30219582, PMID:34870686, PMID:38763208, PMID:37100191]. Mutations in MFN2 cause Charcot-Marie-Tooth type 2A, and a D210V mutation produces multiple mtDNA deletions, establishing that fusion-competent MFN2 is required for mtDNA stability [PMID:29674596, PMID:22189565].","teleology":[{"year":2003,"claim":"Established that MFN2, with MFN1, is essential for mammalian mitochondrial fusion and that fusion is protective, defining the gene's core cell-biological function.","evidence":"Mfn1/Mfn2 knockout MEFs with morphology imaging, genetic rescue, and reciprocal Co-IP","pmids":["12527753"],"confidence":"High","gaps":["Did not resolve the molecular fusion mechanism or GTPase cycle","Did not address non-fusion functions"]},{"year":2011,"claim":"Linked MFN2 dysfunction to genomic instability of the mitochondrial genome, showing fusion is required to maintain mtDNA integrity.","evidence":"Clinical genetics of MFN2 D210V with patient muscle mtDNA deletion analysis and fibroblast repair assays","pmids":["22189565"],"confidence":"Medium","gaps":["Single family study","Mechanism connecting fusion loss to deletion accumulation not defined"]},{"year":2013,"claim":"Identified MFN2 as a signaling regulator, not just a structural fusion protein, by showing it represses PERK at the ER and thereby controls ROS and mitochondrial Ca2+.","evidence":"Reciprocal Co-IP and siRNA epistasis in MEFs under ER stress with ROS/Ca2+/morphology readouts; later corroborated in podocytes","pmids":["23921556","34988075"],"confidence":"High","gaps":["Whether repression is direct enzymatic inhibition or contact-dependent unclear","Structural basis of MFN2-PERK interaction unknown"]},{"year":2013,"claim":"Mapped MFN2 anti-proliferative signaling to distinct domains acting on the Ras-Raf-ERK axis.","evidence":"Domain-fragment Co-IP and rescue in KO MEFs and BJAB cells with proliferation assays","pmids":["24081906"],"confidence":"Medium","gaps":["Single lab","Direct versus scaffold role in pathway inhibition not separated"]},{"year":2014,"claim":"Extended MFN2-dependent contact sites beyond ER to melanosomes, implicating it in secretory organelle biogenesis.","evidence":"Electron tomography of mitochondria-melanosome contacts with knockdown and melanogenesis assays","pmids":["24485836"],"confidence":"Medium","gaps":["Molecular tether at the melanosome interface unidentified","Single lab"]},{"year":2016,"claim":"Connected MFN2 loss to mitochondrial quality control by revealing a compensatory ROS-HIF1α-BNIP3 mitophagy axis in muscle.","evidence":"Skeletal muscle-specific Mfn2 KO mice with mitophagy, ROS, and expression profiling","pmids":["27334614"],"confidence":"High","gaps":["Direct molecular trigger of the adaptive pathway not defined","Tissue-specificity of compensation unclear"]},{"year":2017,"claim":"Defined paralog-specific roles for MFN2 in metabolic tissues, tethering mitochondria to lipid droplets via perilipin 1 and suppressing mTORC2/Akt via HR1.","evidence":"Adipose-specific KO with Co-IP and respirometry; CRISPR MFN2 KO with domain-mapped mTORC2 Co-IP and xenografts","pmids":["28348166","28176801"],"confidence":"High","gaps":["Why MFN1 cannot substitute mechanistically unresolved","mTORC2 finding is single lab, Medium confidence"]},{"year":2018,"claim":"Resolved the intramolecular conformational switch governing fusion and showed PINK1 phosphorylates Ser378 to control it, enabling small-molecule MFN2 agonists.","evidence":"Interface-residue mutagenesis, in vitro PINK1 kinase assays, and agonist treatment in neurons and a CMT2A mouse model","pmids":["29674596"],"confidence":"High","gaps":["In vivo phospho-occupancy and dynamics of Ser378 not quantified","How agonists distinguish open versus closed states structurally incomplete"]},{"year":2018,"claim":"Showed Parkin-dependent ubiquitination of MFN2 is required for ER-mitochondria tethering, coupling a mitophagy ligase to contact-site function.","evidence":"Non-ubiquitinatable MFN2 mutant rescue, Parkin-deficient patient fibroblasts, Co-IP, and Drosophila PD rescue with synthetic linker","pmids":["30219582"],"confidence":"High","gaps":["Specific ubiquitin chain type and topology not defined","How ubiquitination promotes tethering rather than degradation mechanistically unclear"]},{"year":2020,"claim":"Demonstrated in vitro that CMT2A hinge variants impair GTP-dependent cis-oligomerization and fusion, and that cytosolic factors including Bax can compensate.","evidence":"Reconstituted proteoliposome fusion and nucleotide-assembly assays with defined variants plus Bax/cytosol addition","pmids":["32245838"],"confidence":"High","gaps":["Identity of compensating cytosolic factors beyond Bax unknown","Physiological relevance of Bax rescue in neurons untested"]},{"year":2020,"claim":"Placed MFN2 in energy-stress autophagy by showing AMPK directly engages it to drive MAM formation, a paralog-specific role.","evidence":"AMPK-MFN2 Co-IP, Mfn2-null rescue MEFs, EM quantification of MAMs, and metabolic assays","pmids":["32249716"],"confidence":"High","gaps":["Whether AMPK phosphorylates MFN2 directly not established","Order of MAM formation versus autophagy induction unresolved"]},{"year":2021,"claim":"Separated MFN2's ER-localized tethering/bioenergetic function from its mitochondrial fusion function using organelle-targeted constructs.","evidence":"ER- versus mitochondria-targeted Mfn2 rescue in KO neurons with Ca2+ transfer, bioenergetics, and neurite assays; in vivo conditional KO with EM and contact-marker Co-IP","pmids":["34296790","34110411"],"confidence":"High","gaps":["Stoichiometry of ER-Mfn2/mito-Mfn1-2 trans-complex not defined","How the two pools are partitioned in cells unclear"]},{"year":2021,"claim":"Identified VCP cofactor UBXN1 as the machinery extracting MFN2 from the OMM during PRKN-dependent mitophagy.","evidence":"UBXN1 KO cells, Co-IP, fractionation, and super-resolution imaging of MFN2 blobs with mitophagy flux","pmids":["33966597"],"confidence":"Medium","gaps":["Single lab","Whether UBXN1 acts on all ubiquitinated MFN2 pools unclear"]},{"year":2021,"claim":"Established a paralog-distinct requirement for MFN2 in spermatogenesis via dual mitochondrial and ER functions and translational regulation of germ-cell mRNAs.","evidence":"Germ-cell conditional KO with organelle-targeted rescue; Co-IP with nuage proteins and MSY2 plus polysome fractionation","pmids":["32330448","33674260"],"confidence":"Medium","gaps":["Mechanism linking ER/mito function to translation unresolved","Single lab"]},{"year":2022,"claim":"Broadened MFN2's contact-site repertoire to peroxisomes and the nuclear envelope, the latter enabling non-canonical nuclear import of PDC.","evidence":"BioID and dominant-negative truncations for peroxisomes; super-resolution imaging, fractionation, NPC blockade, and PDC-lamin A Co-IP for nuclear envelope","pmids":["35523862","35245450"],"confidence":"Medium","gaps":["Trans-partner at peroxisome and nuclear envelope interfaces unidentified","Functional consequence of nuclear PDC incompletely defined"]},{"year":2022,"claim":"Identified MFN2 as a regulator of metabolic enzyme stability and a hub for receptor downregulation through partner-dependent ubiquitination/dephosphorylation at mitochondria.","evidence":"PFK1-TRIM21 degradation via MFN2 C-terminus (Co-IP, SPR, metabolomics, vein graft) and EGFR-Rab21-MFN2-PTPRJ axis (BLI, Co-IP, kidney KO, xenografts)","pmids":["35450439","37378422"],"confidence":"Medium","gaps":["Generality of MFN2 as a degradation adaptor versus context-specific unclear","Each axis is single lab"]},{"year":2022,"claim":"Characterized how CMT2A R364W perturbs contact-site stability and shifts the MITOL/DRP1 fission-fusion balance toward hyperfusion.","evidence":"MITOL Co-IP with WT versus R364W, DRP1 ubiquitylation/degradation assays, and MAM/Ca2+ measurements","pmids":["34870686","35924634"],"confidence":"Medium","gaps":["MAM-contact finding is Low confidence, overexpression-based","How a single residue rewires ligase availability mechanistically incomplete"]},{"year":2023,"claim":"Established phospho-regulation as a master switch on MFN2 stability and fate, with PGAM5 dephosphorylation favoring fusion and LRRK2 phosphorylation driving degradation.","evidence":"PGAM5-MFN2 Co-IP with phospho/ubiquitin assays and Drosophila epistasis; LRRK2-MKK4/JNK phospho-Ser27 mapping with KO mice","pmids":["37498743","37633049"],"confidence":"Medium","gaps":["Which phosphosites PGAM5 targets not fully mapped","Integration of competing kinase/phosphatase inputs unresolved"]},{"year":2023,"claim":"Connected MFN2-controlled mitochondrial integrity to innate immune and Ca2+ signaling, including cGAS-STING activation upon mtDNA release and SERCA2-tuned Ca2+ in CD8+ T cells.","evidence":"Microglial Sting KO and Mfn2 knockdown with cytosolic mtDNA and pathway assays; CD8+ T cell Mfn2 ablation with SERCA2 Co-IP and tumor models","pmids":["38009491","37738362"],"confidence":"Medium","gaps":["Direct cause of mtDNA leakage from fusion imbalance not pinpointed","Each context single lab"]},{"year":2024,"claim":"Revealed MFN2 control of the microtubule cytoskeleton and refined its endogenous interactome, linking transport and nutrient-responsive partners.","evidence":"MFN2-ATAT1 Co-IP with KO and CMT2A mutant live imaging; CRISPR HA-tagged endogenous interactome by MS validating RAB5C and SLC27A2","pmids":["38883841","39675054"],"confidence":"Medium","gaps":["How CMT2A mutants fail to release ATAT1 structurally unknown","Functional roles of newly validated interactors only partly defined"]},{"year":null,"claim":"How the many post-translational inputs (PINK1, LRRK2, PGAM5, Parkin/MITOL/RBCK1/Mul1, USP2) and the ER-versus-mitochondrial pools are integrated in real time to set MFN2's choice among fusion, tethering, and degradation remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified quantitative model of competing PTMs on MFN2","Structures of trans-tethering and contact-site complexes lacking","Mechanism partitioning ER versus mitochondrial MFN2 pools unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[3,30]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[8,9,29,7]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,13,14]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,19]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,8,9]},{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[4,29]},{"term_id":"GO:0005635","term_label":"nuclear envelope","supporting_discovery_ids":[7]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,8]}],"pathway":[{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[0,3]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[2,5,17]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[1,20]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[13,14,32]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[4,16,29]}],"complexes":["MFN1-MFN2 fusion complex","ER-mitochondria tether (MAM)","mitochondria-lipid droplet contact (Hsc70)"],"partners":["MFN1","PERK","SERCA2","IP3R3","PFK1","HSC70","ATAT1","RAB21"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O95140","full_name":"Mitofusin-2","aliases":["Transmembrane GTPase MFN2"],"length_aa":757,"mass_kda":86.4,"function":"Mitochondrial outer membrane GTPase that mediates mitochondrial clustering and fusion (PubMed:11181170, PubMed:11950885, PubMed:19889647, PubMed:26214738, PubMed:28114303). Mitochondria are highly dynamic organelles, and their morphology is determined by the equilibrium between mitochondrial fusion and fission events (PubMed:28114303). Overexpression induces the formation of mitochondrial networks (PubMed:28114303). Membrane clustering requires GTPase activity and may involve a major rearrangement of the coiled coil domains (Probable). Plays a central role in mitochondrial metabolism and may be associated with obesity and/or apoptosis processes (By similarity). Plays an important role in the regulation of vascular smooth muscle cell proliferation (By similarity). Involved in the clearance of damaged mitochondria via selective autophagy (mitophagy) (PubMed:23620051). Is required for PRKN recruitment to dysfunctional mitochondria (PubMed:23620051). Involved in the control of unfolded protein response (UPR) upon ER stress including activation of apoptosis and autophagy during ER stress (By similarity). Acts as an upstream regulator of EIF2AK3 and suppresses EIF2AK3 activation under basal conditions (By similarity)","subcellular_location":"Mitochondrion outer membrane","url":"https://www.uniprot.org/uniprotkb/O95140/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/MFN2","classification":"Common Essential","n_dependent_lines":940,"n_total_lines":1208,"dependency_fraction":0.7781456953642384},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000116688","cell_line_id":"CID001875","localizations":[{"compartment":"mitochondria","grade":3}],"interactors":[{"gene":"MFN1","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/target/CID001875","total_profiled":1310},"omim":[{"mim_id":"621246","title":"TRAB DOMAIN-CONTAINING PROTEIN; TRABD","url":"https://www.omim.org/entry/621246"},{"mim_id":"620544","title":"PPP1R13B DIVERGENT TRANSCRIPT, NONCODING; PPP1R13BDT","url":"https://www.omim.org/entry/620544"},{"mim_id":"618802","title":"tRNA-HISTIDINE GUANYLYLTRANSFERASE 1-LIKE PROTEIN; THG1L","url":"https://www.omim.org/entry/618802"},{"mim_id":"618800","title":"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 28; SCAR28","url":"https://www.omim.org/entry/618800"},{"mim_id":"617087","title":"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B","url":"https://www.omim.org/entry/617087"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"heart muscle","ntpm":253.1},{"tissue":"skeletal muscle","ntpm":290.9},{"tissue":"tongue","ntpm":315.0}],"url":"https://www.proteinatlas.org/search/MFN2"},"hgnc":{"alias_symbol":["CPRP1","KIAA0214","MARF","CMT2A2"],"prev_symbol":[]},"alphafold":{"accession":"O95140","domains":[{"cath_id":"3.40.50.300","chopping":"97-329","consensus_level":"medium","plddt":89.1928,"start":97,"end":329},{"cath_id":"-","chopping":"545-557_627-652","consensus_level":"medium","plddt":73.6626,"start":545,"end":652}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O95140","model_url":"https://alphafold.ebi.ac.uk/files/AF-O95140-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O95140-F1-predicted_aligned_error_v6.png","plddt_mean":81.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MFN2","jax_strain_url":"https://www.jax.org/strain/search?query=MFN2"},"sequence":{"accession":"O95140","fasta_url":"https://rest.uniprot.org/uniprotkb/O95140.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O95140/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O95140"}},"corpus_meta":[{"pmid":"12527753","id":"PMC_12527753","title":"Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12527753","citation_count":2109,"is_preprint":false},{"pmid":"23921556","id":"PMC_23921556","title":"Mfn2 modulates the UPR and mitochondrial function via repression of PERK.","date":"2013","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/23921556","citation_count":387,"is_preprint":false},{"pmid":"27334614","id":"PMC_27334614","title":"Mfn2 deficiency links age-related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway.","date":"2016","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/27334614","citation_count":333,"is_preprint":false},{"pmid":"16714318","id":"PMC_16714318","title":"MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2.","date":"2006","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16714318","citation_count":320,"is_preprint":false},{"pmid":"32249716","id":"PMC_32249716","title":"The AMPK-MFN2 axis regulates MAM dynamics and autophagy induced by energy stresses.","date":"2020","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/32249716","citation_count":259,"is_preprint":false},{"pmid":"28348166","id":"PMC_28348166","title":"Mfn2 is critical for brown adipose tissue thermogenic function.","date":"2017","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/28348166","citation_count":230,"is_preprint":false},{"pmid":"31281507","id":"PMC_31281507","title":"Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31281507","citation_count":205,"is_preprint":false},{"pmid":"29674596","id":"PMC_29674596","title":"MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A.","date":"2018","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29674596","citation_count":203,"is_preprint":false},{"pmid":"22189565","id":"PMC_22189565","title":"The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype.","date":"2011","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22189565","citation_count":193,"is_preprint":false},{"pmid":"30219582","id":"PMC_30219582","title":"Regulation of ER-mitochondria contacts by Parkin via Mfn2.","date":"2018","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/30219582","citation_count":180,"is_preprint":false},{"pmid":"24485836","id":"PMC_24485836","title":"Mitochondria and melanosomes establish physical contacts modulated by Mfn2 and involved in organelle biogenesis.","date":"2014","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/24485836","citation_count":142,"is_preprint":false},{"pmid":"28176801","id":"PMC_28176801","title":"MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28176801","citation_count":112,"is_preprint":false},{"pmid":"26143526","id":"PMC_26143526","title":"MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives.","date":"2015","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26143526","citation_count":110,"is_preprint":false},{"pmid":"21148429","id":"PMC_21148429","title":"MARF and Opa1 control mitochondrial and cardiac function in Drosophila.","date":"2010","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/21148429","citation_count":108,"is_preprint":false},{"pmid":"32593899","id":"PMC_32593899","title":"Ferroptosis mediated by the interaction between Mfn2 and IREα promotes arsenic-induced nonalcoholic steatohepatitis.","date":"2020","source":"Environmental research","url":"https://pubmed.ncbi.nlm.nih.gov/32593899","citation_count":103,"is_preprint":false},{"pmid":"36367849","id":"PMC_36367849","title":"Isorhapontigenin Attenuates Cardiac Microvascular Injury in Diabetes via the Inhibition of Mitochondria-Associated Ferroptosis Through PRDX2-MFN2-ACSL4 Pathways.","date":"2023","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/36367849","citation_count":100,"is_preprint":false},{"pmid":"24081906","id":"PMC_24081906","title":"Role of mitofusin 2 (Mfn2) in controlling cellular proliferation.","date":"2013","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24081906","citation_count":98,"is_preprint":false},{"pmid":"35154486","id":"PMC_35154486","title":"Overexpression of MFN2 alleviates sorafenib-induced cardiomyocyte necroptosis via the MAM-CaMKIIδ pathway in vitro and in vivo.","date":"2022","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/35154486","citation_count":93,"is_preprint":false},{"pmid":"25147362","id":"PMC_25147362","title":"Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death.","date":"2014","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/25147362","citation_count":93,"is_preprint":false},{"pmid":"34988075","id":"PMC_34988075","title":"Mfn2 Regulates High Glucose-Induced MAMs Dysfunction and Apoptosis in Podocytes via PERK Pathway.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34988075","citation_count":92,"is_preprint":false},{"pmid":"36308626","id":"PMC_36308626","title":"Mfn2-mediated mitochondrial fusion promotes autophagy and suppresses ovarian cancer progression by reducing ROS through AMPK/mTOR/ERK signaling.","date":"2022","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/36308626","citation_count":91,"is_preprint":false},{"pmid":"29436693","id":"PMC_29436693","title":"Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy.","date":"2018","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/29436693","citation_count":87,"is_preprint":false},{"pmid":"35399520","id":"PMC_35399520","title":"The Role of Impaired Mitochondrial Dynamics in MFN2-Mediated Pathology.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35399520","citation_count":84,"is_preprint":false},{"pmid":"23797661","id":"PMC_23797661","title":"Anti-tumor effects of Mfn2 in gastric cancer.","date":"2013","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23797661","citation_count":82,"is_preprint":false},{"pmid":"37738362","id":"PMC_37738362","title":"Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8+ T cell metabolic fitness and function in tumors.","date":"2023","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37738362","citation_count":79,"is_preprint":false},{"pmid":"36765376","id":"PMC_36765376","title":"Morinda officinalis oligosaccharides mitigate depression-like behaviors in hypertension rats by regulating Mfn2-mediated mitophagy.","date":"2023","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/36765376","citation_count":77,"is_preprint":false},{"pmid":"27387769","id":"PMC_27387769","title":"Melatonin prevents adverse myocardial infarction remodeling via Notch1/Mfn2 pathway.","date":"2016","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27387769","citation_count":72,"is_preprint":false},{"pmid":"24905188","id":"PMC_24905188","title":"Dysregulation of Mfn2 and Drp-1 proteins in heart failure.","date":"2014","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24905188","citation_count":70,"is_preprint":false},{"pmid":"31754334","id":"PMC_31754334","title":"MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2.","date":"2019","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31754334","citation_count":70,"is_preprint":false},{"pmid":"31926268","id":"PMC_31926268","title":"Mfn2 is involved in intervertebral disc degeneration through autophagy modulation.","date":"2020","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/31926268","citation_count":69,"is_preprint":false},{"pmid":"32416221","id":"PMC_32416221","title":"MFN2 contributes to metabolic disorders and inflammation in the aging of rat chondrocytes and osteoarthritis.","date":"2020","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/32416221","citation_count":67,"is_preprint":false},{"pmid":"35842187","id":"PMC_35842187","title":"Paeonol protects against doxorubicin-induced cardiotoxicity by promoting Mfn2-mediated mitochondrial fusion through activating the PKCε-Stat3 pathway.","date":"2022","source":"Journal of advanced research","url":"https://pubmed.ncbi.nlm.nih.gov/35842187","citation_count":66,"is_preprint":false},{"pmid":"34110411","id":"PMC_34110411","title":"The role of Mfn2 in the structure and function of endoplasmic reticulum-mitochondrial tethering in vivo.","date":"2021","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/34110411","citation_count":66,"is_preprint":false},{"pmid":"38009491","id":"PMC_38009491","title":"Cytoplasmic Escape of Mitochondrial DNA Mediated by Mfn2 Downregulation Promotes Microglial Activation via cGas-Sting Axis in Spinal Cord Injury.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38009491","citation_count":62,"is_preprint":false},{"pmid":"34026850","id":"PMC_34026850","title":"Mitochondrial Fusion Protein Mfn2 and Its Role in Heart Failure.","date":"2021","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/34026850","citation_count":61,"is_preprint":false},{"pmid":"34296790","id":"PMC_34296790","title":"Mfn2 localization in the ER is necessary for its bioenergetic function and neuritic development.","date":"2021","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/34296790","citation_count":61,"is_preprint":false},{"pmid":"35245450","id":"PMC_35245450","title":"MFN2-driven mitochondria-to-nucleus tethering allows a non-canonical nuclear entry pathway of the mitochondrial pyruvate dehydrogenase complex.","date":"2022","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/35245450","citation_count":58,"is_preprint":false},{"pmid":"38311582","id":"PMC_38311582","title":"Mfn2/Hsc70 Complex Mediates the Formation of Mitochondria-Lipid Droplets Membrane Contact and Regulates Myocardial Lipid Metabolism.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38311582","citation_count":56,"is_preprint":false},{"pmid":"38566081","id":"PMC_38566081","title":"Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of Parkinson's disease through Mfn2-cGAS signaling.","date":"2024","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/38566081","citation_count":55,"is_preprint":false},{"pmid":"31947766","id":"PMC_31947766","title":"Mfn2 Ablation in the Adult Mouse Hippocampus and Cortex Causes Neuronal Death.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31947766","citation_count":54,"is_preprint":false},{"pmid":"37537600","id":"PMC_37537600","title":"Decreased MFN2 activates the cGAS-STING pathway in diabetic myocardial ischaemia-reperfusion by triggering the release of mitochondrial DNA.","date":"2023","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/37537600","citation_count":53,"is_preprint":false},{"pmid":"30158064","id":"PMC_30158064","title":"MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue.","date":"2018","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/30158064","citation_count":53,"is_preprint":false},{"pmid":"31654396","id":"PMC_31654396","title":"PTEN inhibition attenuates endothelial cell apoptosis in coronary heart disease via modulating the AMPK-CREB-Mfn2-mitophagy signaling pathway.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31654396","citation_count":50,"is_preprint":false},{"pmid":"25978725","id":"PMC_25978725","title":"Mfn2 Affects Embryo Development via Mitochondrial Dysfunction and Apoptosis.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25978725","citation_count":49,"is_preprint":false},{"pmid":"36158213","id":"PMC_36158213","title":"MFN2 mediates ER-mitochondrial coupling during ER stress through specialized stable contact sites.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/36158213","citation_count":46,"is_preprint":false},{"pmid":"35523862","id":"PMC_35523862","title":"The MFN1 and MFN2 mitofusins promote clustering between mitochondria and peroxisomes.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/35523862","citation_count":44,"is_preprint":false},{"pmid":"26931463","id":"PMC_26931463","title":"Drosophila clueless is involved in Parkin-dependent mitophagy by promoting VCP-mediated Marf degradation.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26931463","citation_count":39,"is_preprint":false},{"pmid":"38110986","id":"PMC_38110986","title":"Role of mitochondrial fusion proteins MFN2 and OPA1 on lung cellular senescence in chronic obstructive pulmonary disease.","date":"2023","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/38110986","citation_count":38,"is_preprint":false},{"pmid":"35450439","id":"PMC_35450439","title":"MFN2 Prevents Neointimal Hyperplasia in Vein Grafts via Destabilizing PFK1.","date":"2022","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/35450439","citation_count":38,"is_preprint":false},{"pmid":"37498743","id":"PMC_37498743","title":"PGAM5 is an MFN2 phosphatase that plays an essential role in the regulation of mitochondrial dynamics.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37498743","citation_count":37,"is_preprint":false},{"pmid":"34120306","id":"PMC_34120306","title":"MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.","date":"2021","source":"Cardiovascular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34120306","citation_count":37,"is_preprint":false},{"pmid":"37252276","id":"PMC_37252276","title":"Ginsenoside compound K protects against cerebral ischemia/reperfusion injury via Mul1/Mfn2-mediated mitochondrial dynamics and bioenergy.","date":"2022","source":"Journal of ginseng research","url":"https://pubmed.ncbi.nlm.nih.gov/37252276","citation_count":36,"is_preprint":false},{"pmid":"33454007","id":"PMC_33454007","title":"Mycobacterium tuberculosis infection up-regulates MFN2 expression to promote NLRP3 inflammasome formation.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33454007","citation_count":34,"is_preprint":false},{"pmid":"32330448","id":"PMC_32330448","title":"MFN2 Plays a Distinct Role from MFN1 in Regulating Spermatogonial Differentiation.","date":"2020","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32330448","citation_count":34,"is_preprint":false},{"pmid":"28324764","id":"PMC_28324764","title":"Enhancing Mitofusin/Marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies.","date":"2017","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/28324764","citation_count":32,"is_preprint":false},{"pmid":"33966597","id":"PMC_33966597","title":"VCP/p97 cofactor UBXN1/SAKS1 regulates mitophagy by modulating MFN2 removal from mitochondria.","date":"2021","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/33966597","citation_count":32,"is_preprint":false},{"pmid":"34019822","id":"PMC_34019822","title":"Vmp1, Vps13D, and Marf/Mfn2 function in a conserved pathway to regulate mitochondria and ER contact in development and disease.","date":"2021","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/34019822","citation_count":31,"is_preprint":false},{"pmid":"35472764","id":"PMC_35472764","title":"Mitofusins Mfn1 and Mfn2 Are Required to Preserve Glucose- but Not Incretin-Stimulated β-Cell Connectivity and Insulin Secretion.","date":"2022","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/35472764","citation_count":28,"is_preprint":false},{"pmid":"36283455","id":"PMC_36283455","title":"TRPV4 interacts with MFN2 and facilitates endoplasmic reticulum-mitochondrial contact points for Ca2+-buffering.","date":"2022","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36283455","citation_count":25,"is_preprint":false},{"pmid":"37378422","id":"PMC_37378422","title":"MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria-dependent dephosphorylation of EGFR.","date":"2023","source":"Cancer communications (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37378422","citation_count":24,"is_preprint":false},{"pmid":"35418194","id":"PMC_35418194","title":"Clinical and genetic features of a cohort of patients with MFN2-related neuropathy.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35418194","citation_count":24,"is_preprint":false},{"pmid":"33609088","id":"PMC_33609088","title":"USP30 protects against oxygen-glucose deprivation/reperfusion induced mitochondrial fragmentation and ubiquitination and degradation of MFN2.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/33609088","citation_count":24,"is_preprint":false},{"pmid":"37633049","id":"PMC_37633049","title":"LRRK2 aggravates kidney injury through promoting MFN2 degradation and abnormal mitochondrial integrity.","date":"2023","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/37633049","citation_count":23,"is_preprint":false},{"pmid":"34870686","id":"PMC_34870686","title":"MITOL-mediated DRP1 ubiquitylation and degradation promotes mitochondrial hyperfusion in a CMT2A-linked MFN2 mutant.","date":"2022","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/34870686","citation_count":23,"is_preprint":false},{"pmid":"31276298","id":"PMC_31276298","title":"E2F1 activates MFN2 expression by binding to the promoter and decreases mitochondrial fission and mitophagy in HeLa cells.","date":"2019","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/31276298","citation_count":23,"is_preprint":false},{"pmid":"31384172","id":"PMC_31384172","title":"Mfn2 inhibits proliferation and cell-cycle in Hela cells via Ras-NF-κB signal pathway.","date":"2019","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/31384172","citation_count":22,"is_preprint":false},{"pmid":"32525045","id":"PMC_32525045","title":"The distinctive role of tau and amyloid beta in mitochondrial dysfunction through alteration in Mfn2 and Drp1 mRNA Levels: A comparative study in Drosophila melanogaster.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32525045","citation_count":22,"is_preprint":false},{"pmid":"26801520","id":"PMC_26801520","title":"MFN2-related genetic and clinical features in a cohort of Chinese CMT2 patients.","date":"2016","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/26801520","citation_count":22,"is_preprint":false},{"pmid":"35067795","id":"PMC_35067795","title":"LncRNA NEAT1 ameliorate ischemic stroke via promoting Mfn2 expression through binding to Nova and activates Sirt3.","date":"2022","source":"Metabolic brain disease","url":"https://pubmed.ncbi.nlm.nih.gov/35067795","citation_count":21,"is_preprint":false},{"pmid":"35090998","id":"PMC_35090998","title":"Lanthanum decreased VAPB-PTPP51, BAP31-FIS1, and MFN2-MFN1 expression of mitochondria-associated membranes and induced abnormal autophagy in rat hippocampus.","date":"2022","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/35090998","citation_count":20,"is_preprint":false},{"pmid":"20940517","id":"PMC_20940517","title":"HSG/Mfn2 gene polymorphism and essential hypertension: a case-control association study in Chinese.","date":"2010","source":"Journal of atherosclerosis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/20940517","citation_count":19,"is_preprint":false},{"pmid":"26114802","id":"PMC_26114802","title":"MFN2 deletion of exons 7 and 8: founder mutation in the UK population.","date":"2015","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/26114802","citation_count":19,"is_preprint":false},{"pmid":"32377725","id":"PMC_32377725","title":"Mammalian STE20‑like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2‑mediated mitophagy.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/32377725","citation_count":18,"is_preprint":false},{"pmid":"38883841","id":"PMC_38883841","title":"MFN2 coordinates mitochondria motility with α-tubulin acetylation and this regulation is disrupted in CMT2A.","date":"2024","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/38883841","citation_count":17,"is_preprint":false},{"pmid":"40128893","id":"PMC_40128893","title":"Mfn2 regulates calcium homeostasis and suppresses PASMCs proliferation via interaction with IP3R3 to mitigate pulmonary arterial hypertension.","date":"2025","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40128893","citation_count":17,"is_preprint":false},{"pmid":"38007410","id":"PMC_38007410","title":"Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A.","date":"2023","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/38007410","citation_count":17,"is_preprint":false},{"pmid":"37106782","id":"PMC_37106782","title":"Metformin Collaborates with PINK1/Mfn2 Overexpression to Prevent Cardiac Injury by Improving Mitochondrial Function.","date":"2023","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/37106782","citation_count":17,"is_preprint":false},{"pmid":"37696382","id":"PMC_37696382","title":"Down-regulation of the mitochondrial fusion protein Opa1/Mfn2 promotes cardiomyocyte hypertrophy in Su5416/hypoxia-induced pulmonary hypertension rats.","date":"2023","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/37696382","citation_count":17,"is_preprint":false},{"pmid":"33450208","id":"PMC_33450208","title":"Marf-mediated mitochondrial fusion is imperative for the development and functioning of indirect flight muscles (IFMs) in drosophila.","date":"2021","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/33450208","citation_count":16,"is_preprint":false},{"pmid":"35467292","id":"PMC_35467292","title":"CircHIPK3 Regulates Vascular Smooth Muscle Cell Calcification Via the miR-106a-5p/MFN2 Axis.","date":"2022","source":"Journal of cardiovascular translational research","url":"https://pubmed.ncbi.nlm.nih.gov/35467292","citation_count":16,"is_preprint":false},{"pmid":"38089747","id":"PMC_38089747","title":"Resveratrol activation of SIRT1/MFN2 can improve mitochondria function, alleviating doxorubicin-induced myocardial injury.","date":"2023","source":"Cancer innovation","url":"https://pubmed.ncbi.nlm.nih.gov/38089747","citation_count":16,"is_preprint":false},{"pmid":"33749943","id":"PMC_33749943","title":"Low abundance of Mfn2 protein correlates with reduced mitochondria-SR juxtaposition and mitochondrial cristae density in human men skeletal muscle: Examining organelle measurements from TEM images.","date":"2021","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/33749943","citation_count":16,"is_preprint":false},{"pmid":"38763208","id":"PMC_38763208","title":"E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradation.","date":"2024","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38763208","citation_count":15,"is_preprint":false},{"pmid":"23733358","id":"PMC_23733358","title":"Ethambutol toxicity exacerbating the phenotype of CMT2A2.","date":"2013","source":"Muscle & nerve","url":"https://pubmed.ncbi.nlm.nih.gov/23733358","citation_count":15,"is_preprint":false},{"pmid":"33674260","id":"PMC_33674260","title":"MFN2 interacts with nuage-associated proteins and is essential for male germ cell development by controlling mRNA fate during spermatogenesis.","date":"2021","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33674260","citation_count":15,"is_preprint":false},{"pmid":"32245838","id":"PMC_32245838","title":"Defective nucleotide-dependent assembly and membrane fusion in Mfn2 CMT2A variants improved by Bax.","date":"2020","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/32245838","citation_count":15,"is_preprint":false},{"pmid":"38677536","id":"PMC_38677536","title":"Ginsenoside Rb1 ameliorates lipotoxicity-induced myocardial injury in diabetes mellitus by regulating Mfn2.","date":"2024","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38677536","citation_count":15,"is_preprint":false},{"pmid":"35924634","id":"PMC_35924634","title":"CMT2A-linked mitochondrial hyperfusion-driving mutant MFN2 perturbs ER-mitochondrial associations and Ca2+ homeostasis.","date":"2022","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/35924634","citation_count":15,"is_preprint":false},{"pmid":"35958608","id":"PMC_35958608","title":"Mfn2 is responsible for inhibition of the RIG-I/IRF7 pathway and activation of NLRP3 inflammasome in Seneca Valley virus-infected PK-15 cells to promote viral replication.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35958608","citation_count":15,"is_preprint":false},{"pmid":"36682578","id":"PMC_36682578","title":"MORN4 protects cardiomyocytes against ischemic injury via MFN2-mediated mitochondrial dynamics and mitophagy.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36682578","citation_count":14,"is_preprint":false},{"pmid":"36803920","id":"PMC_36803920","title":"Crosstalk between Mfn2-mediated mitochondria associated membranes disorder and autophagy induced by molybdenum and cadmium in sheep heart.","date":"2023","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/36803920","citation_count":14,"is_preprint":false},{"pmid":"38368414","id":"PMC_38368414","title":"DIAPH1-MFN2 interaction decreases the endoplasmic reticulum-mitochondrial distance and promotes cardiac injury following myocardial ischemia.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38368414","citation_count":12,"is_preprint":false},{"pmid":"37060270","id":"PMC_37060270","title":"Rab26 promotes macrophage phagocytosis through regulation of MFN2 trafficking to mitochondria.","date":"2023","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/37060270","citation_count":12,"is_preprint":false},{"pmid":"35088561","id":"PMC_35088561","title":"MiR-195 promotes pancreatic β-cell dedifferentiation by targeting Mfn2 and impairing Pi3k/Akt signaling in type 2 diabetes.","date":"2022","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/35088561","citation_count":12,"is_preprint":false},{"pmid":"31220477","id":"PMC_31220477","title":"Sphingosine kinase 1 overexpression induces MFN2 fragmentation and alters mitochondrial matrix Ca2+ handling in HeLa cells.","date":"2019","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31220477","citation_count":12,"is_preprint":false},{"pmid":"37100191","id":"PMC_37100191","title":"Angiotensin II-induced calcium overload affects mitochondrial functions in cardiac hypertrophy by targeting the USP2/MFN2 axis.","date":"2023","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37100191","citation_count":12,"is_preprint":false},{"pmid":"38704082","id":"PMC_38704082","title":"Mfn2 regulates mitochondria and mitochondria-associated endoplasmic reticulum membrane function in neurodegeneration induced by repeated sevoflurane exposure.","date":"2024","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/38704082","citation_count":12,"is_preprint":false},{"pmid":"36966125","id":"PMC_36966125","title":"AGK2 pre-treatment protects against thioacetamide-induced acute liver failure via regulating the MFN2-PERK axis and ferroptosis signaling pathway.","date":"2023","source":"Hepatobiliary & pancreatic diseases international : HBPD INT","url":"https://pubmed.ncbi.nlm.nih.gov/36966125","citation_count":11,"is_preprint":false},{"pmid":"39675054","id":"PMC_39675054","title":"Endogenous interactomes of MFN1 and MFN2 provide novel insights into interorganelle communication and autophagy.","date":"2024","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/39675054","citation_count":10,"is_preprint":false},{"pmid":"34721278","id":"PMC_34721278","title":"The Genotype and Phenotype Features in a Large Chinese MFN2 Mutation Cohort.","date":"2021","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/34721278","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53869,"output_tokens":11703,"usd":0.168576,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":22601,"output_tokens":6400,"usd":0.136502,"stage2_stop_reason":"end_turn"},"total_usd":0.305078,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Mfn1 and Mfn2 are both required for mitochondrial fusion in mammalian cells; loss of either causes severe mitochondrial fragmentation. Mfn1 and Mfn2 form homotypic (Mfn1-Mfn1, Mfn2-Mfn2) and heterotypic (Mfn1-Mfn2) complexes, and homotypic complexes are functional for fusion. A subset of mitochondria in mutant cells lose membrane potential, indicating that fusion has a protective role.\",\n      \"method\": \"Mfn1 and Mfn2 knockout mouse embryonic fibroblasts, mitochondrial morphology imaging, genetic rescue, co-immunoprecipitation to detect homotypic and heterotypic complexes\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, KO MEF rescue experiments, multiple orthogonal methods, widely replicated foundational study\",\n      \"pmids\": [\"12527753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Mfn2 physically interacts with PERK at the ER and acts as an upstream repressor of PERK kinase activity. Mfn2-ablated cells show sustained basal PERK activation; PERK silencing in Mfn2-null cells reduces ROS production, normalizes mitochondrial calcium, and improves mitochondrial morphology.\",\n      \"method\": \"Co-immunoprecipitation to detect Mfn2-PERK interaction; siRNA knockdown of Mfn2, PERK, and XBP-1 in MEFs with ER stress induction; measurement of ROS, mitochondrial calcium, and morphology\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, multiple genetic knockdowns, multiple functional readouts, single lab\",\n      \"pmids\": [\"23921556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Mfn2 deficiency in skeletal muscle reduces autophagy and impairs mitochondrial quality. Aging-induced Mfn2 decrease triggers a ROS-dependent adaptive signaling pathway via HIF1α and BNIP3 to compensate for lost mitophagy and minimize mitochondrial damage.\",\n      \"method\": \"Skeletal muscle-specific Mfn2 knockout mice; gene expression profiling, mitophagy/autophagy assays, ROS and HIF1α/BNIP3 measurements\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO mouse model, multiple orthogonal functional readouts, single lab\",\n      \"pmids\": [\"27334614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MFN2 fusion activity is regulated by an intramolecular interaction between Met376/His380 and Asp725/Leu727; PINK1 kinase phosphorylates adjacent Ser378, controlling this interaction. Small-molecule mimics of this peptide-peptide interface allosterically activate MFN2 and promote mitochondrial fusion, overcoming dominant CMT2A-mutant MFN2-induced mitochondrial defects.\",\n      \"method\": \"Mutagenesis of MFN2 interaction residues; PINK1 kinase phosphorylation assays; small-molecule agonist treatment in cultured neurons and CMT2A mouse model; assessment of mitochondrial trafficking, morphology, membrane potential\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis of catalytic/interface residues, in vitro kinase assay, in vivo mouse model, multiple orthogonal functional readouts\",\n      \"pmids\": [\"29674596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Mfn2 directly interacts with perilipin 1 in brown adipose tissue, facilitating physical and functional contacts between mitochondria and lipid droplets in response to adrenergic stimulation. Mfn2, but not Mfn1, deficiency in BAT leads to impaired respiratory capacity and blunted adrenergic response.\",\n      \"method\": \"Adipose-specific Mfn2 knockout mice; Co-immunoprecipitation of Mfn2-perilipin 1; confocal imaging of mitochondria-lipid droplet contacts; respiratory capacity measurements\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific KO, Co-IP, live-cell imaging, multiple functional readouts, single lab\",\n      \"pmids\": [\"28348166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"AMPK directly interacts with MFN2 and translocates to the MAM and mitochondria under energy stress. MFN2 (but not MFN1) is required for energy stress-induced autophagy and MAM formation; re-expression of MFN2 in Mfn2-null MEFs rescues autophagy defects.\",\n      \"method\": \"Co-immunoprecipitation of AMPK-MFN2; Mfn2-knockout and Mfn2-null rescue MEFs; MAM quantification by electron microscopy; oxygen consumption rate and glycolysis measurements\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct Co-IP, genetic KO with rescue, electron microscopy, multiple functional readouts, single lab\",\n      \"pmids\": [\"32249716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MFN2 physically interacts with SERCA2 (ER-embedded Ca2+-ATPase) at mitochondria-ER contact sites in CD8+ T cells, enhancing ER-mitochondria tethering and facilitating mitochondrial Ca2+ influx for efficient mitochondrial metabolism. MFN2 also stimulates SERCA2 ER Ca2+ retrieval activity, preventing excessive mitochondrial Ca2+ accumulation and apoptosis.\",\n      \"method\": \"Genetic ablation of Mfn2 in CD8+ T cells; Co-immunoprecipitation of MFN2-SERCA2; Ca2+ flux measurements; mitochondrial metabolic assays; tumor immunotherapy models\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, conditional KO, multiple Ca2+ and metabolic assays, in vivo tumor model, single lab\",\n      \"pmids\": [\"37738362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MFN2 drives mitochondria to cluster and tether onto the nuclear envelope via MFN2-enriched contact points. Mitochondrial PDC (pyruvate dehydrogenase complex) crosses the nuclear envelope through a non-canonical pathway (independent of nuclear pore complexes) at these MFN2-dependent tethering sites, interacting with lamin A; reduced nuclear MFN2 decreases mitochondria tethering and nuclear PDC levels.\",\n      \"method\": \"Live imaging and super-resolution microscopy of mitochondria-nuclear envelope contacts; nuclear fractionation; pharmacological NPC blockade; Co-immunoprecipitation of PDC-lamin A; siRNA knockdown of MFN2\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — reconstitution-style fractionation, Co-IP, pharmacological and genetic perturbation, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"35245450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Mfn2 localization to the ER (not mitochondria) is required for its bioenergetic function. ER-located Mfn2 interacts with mitochondrial Mfn1/2 to tether ER and mitochondria, enabling Ca2+ transfer from ER to mitochondria, which enhances mitochondrial metabolism. This ER-localized function is also necessary for proper neuritic outgrowth.\",\n      \"method\": \"ER-targeted vs. mitochondria-targeted Mfn2 constructs in Mfn2 KO neurons; Co-immunoprecipitation; Ca2+ transfer assays; mitochondrial bioenergetics measurements; neurite outgrowth assays; artificial ER-mitochondria tether rescue\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — targeted constructs, Co-IP, Ca2+ assays, genetic KO with organelle-specific rescue, multiple readouts, single lab\",\n      \"pmids\": [\"34296790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In vivo Mfn2 conditional knockout in hippocampal and cortical pyramidal neurons reduces ER-mitochondria close contacts and decreases mitochondrial Ca2+ uptake and IP3R3-Grp75 interaction. Mfn2 overexpression increases ER-mitochondria contacts and the VAPB-PTPIP51 tethering pair interaction, supporting Mfn2 as a positive regulator of ER-mitochondrial tethering in vivo.\",\n      \"method\": \"Mfn2 conditional KO and overexpression mice; electron microscopy for ultrastructural quantification of ER-mitochondria contacts; biochemical fractionation; Co-immunoprecipitation of IP3R3-Grp75 and VAPB-PTPIP51\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo conditional KO and OE, electron microscopy, Co-IP, multiple contact-site markers, single lab\",\n      \"pmids\": [\"34110411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PGAM5 phosphatase interacts with MFN2 in a stress-sensitive manner and dephosphorylates MFN2 to protect it from ubiquitination and degradation, thereby promoting mitochondrial fusion. Phosphorylation of MFN2 enhances fission and degradation, while dephosphorylation enhances fusion. Drosophila genetic epistasis places Marf (MFN2 ortholog) and dPGAM5 in the same biological pathway.\",\n      \"method\": \"Co-immunoprecipitation of PGAM5-MFN2; phosphorylation and ubiquitination assays; mitochondrial morphology imaging; Drosophila genetic epistasis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, biochemical phosphorylation/ubiquitination assays, genetic epistasis in Drosophila, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"37498743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Drosophila Clu promotes VCP/p97-dependent Marf (MFN2 ortholog) degradation in the context of Parkin-mediated mitophagy; Clu binds VCP in vivo, and overexpression of Clu destabilizes Marf in vitro. This degradation step is required for progression of mitophagy.\",\n      \"method\": \"Drosophila genetic epistasis (clu, PINK1, parkin mutants); in vivo Co-IP of Clu-VCP; in vitro Marf degradation assay; confocal imaging of mitochondrial clearance\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo Co-IP, in vitro degradation assay, genetic epistasis, but Drosophila ortholog only\",\n      \"pmids\": [\"26931463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Parkin-dependent ubiquitination of Mfn2 at a specific site is required for ER-mitochondria tethering. In Parkin-deficient cells and patient fibroblasts, ER-mitochondria tethering is decreased. A non-ubiquitinatable Mfn2 mutant fails to restore ER-mitochondria physical and functional interaction.\",\n      \"method\": \"Co-immunoprecipitation; Parkin-deficient cells and parkin mutant human fibroblasts; non-ubiquitinatable Mfn2 mutant rescue experiments; Drosophila PD model behavioral rescue with synthetic ER-mitochondria linker\",\n      \"journal\": \"Pharmacological research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis of ubiquitination site, patient fibroblasts, Co-IP, in vivo Drosophila rescue, multiple orthogonal methods\",\n      \"pmids\": [\"30219582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MFN2 suppresses mTORC2/Akt signaling by directly interacting with mTORC2 through its HR1 domain. MFN2 knockout in cancer cells elevates mTORC2 activity and promotes AktS473 phosphorylation-mediated cancer growth and metastasis.\",\n      \"method\": \"CRISPR/Cas9 MFN2 knockout in MCF7 and A549 cells; Co-immunoprecipitation of MFN2-mTORC2; domain mapping (HR1 fragment); xenograft tumor model; signaling analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP with domain mapping, genetic KO, in vivo xenograft, single lab\",\n      \"pmids\": [\"28176801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Endogenous Mfn2 inhibits cell proliferation by acting as an effector of Ras, inhibiting the Ras-Raf-ERK signaling pathway. The N-terminal fragment (aa 1-264) interacts with Raf-1, while the C-terminal fragment (aa 265-757) interacts with Ras to inhibit proliferation through distinct mechanisms.\",\n      \"method\": \"Mfn2 knockdown in BJAB cells and Mfn2 KO MEFs; reintroduction of Mfn2 fragments; Co-immunoprecipitation of N-term Mfn2 with Raf-1 and C-term Mfn2 with Ras; proliferation assays\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP with domain fragments, KO MEFs, genetic rescue, single lab\",\n      \"pmids\": [\"24081906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Mfn2 physically contacts melanosomes through fibrillar bridges in pigment cells, and Mfn2 knockdown significantly reduces mitochondria-melanosome connections. Mfn2 loss prevents OA1-stimulated melanogenesis, linking Mfn2-dependent contacts to secretory organelle biogenesis.\",\n      \"method\": \"Electron tomography of mitochondria-melanosome contacts; Mfn2 knockdown; immunolocalization of Mfn2 at contact sites; melanogenesis assays\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electron tomography, genetic knockdown with functional readout, single lab\",\n      \"pmids\": [\"24485836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MFN2 physically interacts with PFK1 (phosphofructokinase 1) through its C-terminus, promoting PFK1 ubiquitin-proteasome dependent degradation by facilitating the association between PFK1 and E3 ligase TRIM21. MFN2 downregulation by mechanical stretch stabilizes PFK1, shifts metabolism toward glycolysis, and promotes VSMC proliferation/migration.\",\n      \"method\": \"Co-immunoprecipitation, pull-down, surface plasmon resonance, mutagenesis of MFN2 C-terminus; metabolomics; VSMC stretch model; vein graft mouse model\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — reciprocal Co-IP, pull-down, SPR biophysical binding, mutagenesis, metabolomics, in vivo model, single lab\",\n      \"pmids\": [\"35450439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"VCP cofactor UBXN1 facilitates MFN2 removal from the outer mitochondrial membrane during PRKN-dependent mitophagy. Loss of UBXN1 impairs MFN2 extraction, leading to accumulation of para-mitochondrial MFN2 blobs and impaired PRKN translocation to depolarized mitochondria.\",\n      \"method\": \"UBXN1 knockout cells; Co-immunoprecipitation of UBXN1-PRKN (UBX domain dependent); mitochondrial fractionation; mitophagy flux assays; confocal and super-resolution imaging of MFN2 blobs\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, genetic KO, fractionation, mitophagy assays, single lab\",\n      \"pmids\": [\"33966597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Vps13D functions upstream of Marf/MFN2 in a conserved pathway regulating mitochondria-ER contact sites; vps13d mutants accumulate elevated Marf/MFN2 levels, and loss of marf/MFN2 suppresses vps13d mutant phenotypes including enlarged mitochondria-ER contacts and autophagy defects.\",\n      \"method\": \"Drosophila genetic epistasis (vmp1, vps13d, marf double/triple mutants); human cell VPS13D knockdown and MFN2 rescue; electron microscopy; autophagy assays\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in Drosophila and human cells, electron microscopy, single lab\",\n      \"pmids\": [\"34019822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MFN1 and MFN2 promote clustering between mitochondria and peroxisomes; MFNs are enriched at the mitochondria-peroxisome interface, and a truncated MFN2 lacking the transmembrane region inhibits peroxisome-mitochondria tethering.\",\n      \"method\": \"Proximity labeling (BioID) with peroxisomal proteins; overexpression of MFNs; confocal microscopy of co-clustering; dominant-negative truncated MFN2 expression\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — proximity labeling, overexpression/dominant-negative, imaging, single lab\",\n      \"pmids\": [\"35523862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MFN2-stabilized MAMs increase in lifetime and stability during ER stress. MFN2 knockdown blunts mitochondrial Ca2+ uptake during ER stress, switches mitochondrial F1FO-ATPase into reverse mode, and strongly reduces ATP supply to the ER during ER stress.\",\n      \"method\": \"Structured illumination super-resolution microscopy of MAMs; MFN2 knockdown; mitochondrial Ca2+ measurements; OXPHOS and ATP assays during ER stress induction\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — super-resolution imaging, genetic knockdown, Ca2+ and bioenergetic assays, single lab\",\n      \"pmids\": [\"36158213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In Drosophila, MARF (MFN2 ortholog) knockdown in heart tubes increases mitochondrial heterogeneity and induces cardiomyopathy, rescued by human MFN1 or MFN2, demonstrating functional homology. Reactive oxygen species mediate the cardiomyopathy in mitochondrial fusion-defective cardiomyocytes; SOD1 expression prevents the phenotype.\",\n      \"method\": \"Drosophila heart tube-specific RNAi of MARF; live imaging; human MFN1/MFN2 rescue; transgenic SOD1 overexpression; cardiomyocyte morphometric analysis\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Drosophila genetic model, cross-species rescue establishing functional homology, live imaging, single lab\",\n      \"pmids\": [\"21148429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In excitotoxicity, Mfn2 expression is downregulated via MEF2 transcription factor degradation. Mfn2 reduction causes mitochondrial dysfunction, altered calcium homeostasis, enhanced Bax translocation to mitochondria, and delayed neuronal death. MEF2 regulates basal Mfn2 expression in neurons.\",\n      \"method\": \"In vitro and in vivo excitotoxicity models; siRNA knockdown of Mfn2; MEF2 knockdown and overexpression; measurement of MEF2 binding to Mfn2 promoter; mitochondrial membrane potential and Bax translocation assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockdown, promoter binding assay, multiple functional readouts, in vivo and in vitro, single lab\",\n      \"pmids\": [\"25147362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Mfn2 physically interacts with PERK in podocytes; high-glucose conditions decrease Mfn2-PERK interaction, and Mfn2 silencing activates the PERK pathway, causing MAM reduction, mitochondrial dysfunction, and increased apoptosis. Mfn2 overexpression inhibits PERK activation and is anti-apoptotic, and PERK inhibition does not affect Mfn2 levels, placing Mfn2 upstream of PERK.\",\n      \"method\": \"Co-immunoprecipitation of Mfn2-PERK; Mfn2 siRNA knockdown and overexpression in podocytes; PERK inhibitor treatment; mitochondrial morphology and MAM quantification; apoptosis assays\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP, genetic KO/OE, epistasis by inhibitor, multiple functional readouts, single lab\",\n      \"pmids\": [\"34988075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The CMT2A-associated MFN2 mutant R364W causes mitochondrial hyperfusion due to enhanced DRP1 ubiquitylation and proteasomal degradation by MITOL/MARCHF5. MITOL preferentially ubiquitylates wild-type MFN2 over R364W-MFN2, making the ligase more available for DRP1 multi-monoubiquitylation and degradation.\",\n      \"method\": \"Co-immunoprecipitation of MITOL with WT vs. R364W MFN2; ubiquitylation assays; proteasome inhibitor treatment; DRP1 degradation assays; mitochondrial morphology imaging\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP comparison, ubiquitylation assay, pharmacological inhibition, single lab\",\n      \"pmids\": [\"34870686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LRRK2 kinase phosphorylates MFN2 at Ser27 via LRRK2-MKK4/JNK signaling, promoting ubiquitination-mediated MFN2 degradation and subsequent mitochondrial fragmentation in renal tubular cells. Lrrk2-knockout mice show MFN2 accumulation and reduced AKI severity.\",\n      \"method\": \"LRRK2 overexpression and Lrrk2 knockout mouse model; phospho-MFN2-Ser27 detection; Co-IP; JNK pathway inhibitor studies; mitochondrial morphology and ROS measurements\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphorylation site identification, KO mouse, Co-IP, in vivo functional readout, single lab\",\n      \"pmids\": [\"37633049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mfn2 interacts with MFN1 in testes and with nuage-associated proteins (MIWI, DDX4, TDRKH, GASZ); MFN2 also interacts with MSY2 in polysome fractions to regulate translation of gamete-specific mRNAs such as Spata19 during spermatogenesis. MFN2 conditional knockout in postnatal germ cells causes male sterility.\",\n      \"method\": \"Co-immunoprecipitation of MFN2 with nuage proteins and MSY2; polysome fractionation; conditional Mfn2 KO in postnatal germ cells; Mfn1/Mfn2 double KO; translational activity assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with multiple partners, polysome fractionation, conditional KO, single lab\",\n      \"pmids\": [\"33674260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Mfn2 ablation specifically in spermatogonia causes DNA oxidation and apoptosis in differentiating spermatogonia and spermatocytes, causing male infertility. MFN2 regulates spermatogenesis by modulating both mitochondrial and ER functions, a distinct mechanism from MFN1; MFN2 defects are rescued only by MFN2 targeted to either organelle, not by MFN1.\",\n      \"method\": \"Mfn2 conditional KO in germ cells; Mfn1 conditional KO; organelle-targeted Mfn2 rescue constructs; DNA oxidation and apoptosis assays\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO, organelle-targeted rescue, multiple readouts, single lab\",\n      \"pmids\": [\"32330448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MFN2 recruits α-tubulin acetyltransferase 1 (ATAT1) to sites of mitochondria-microtubule contact, promoting local α-tubulin acetylation. This activity is required for MFN2-dependent regulation of mitochondrial transport. CMT2A-associated MFN2 mutations R94W and T105M cannot properly release ATAT1 at these contact sites, linking this function to axonal degeneration.\",\n      \"method\": \"Live imaging of mitochondria-microtubule contacts; Co-immunoprecipitation of MFN2-ATAT1; MFN2 KO and CMT2A mutant expression; measurement of α-tubulin acetylation and mitochondrial motility in neurons\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, KO, disease mutant comparison, live imaging, single lab\",\n      \"pmids\": [\"38883841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Mfn2 forms a complex with Hsc70 at mitochondria-lipid droplet contact (MLC) sites; mitochondrion-localized Mfn2 interacts with LD-localized Hsc70, tethering mitochondria to lipid droplets and facilitating fatty acid transfer from LDs to mitochondria for β-oxidation. Prolonged lipid overload induces MFN2 acetylation at K243 and subsequent ubiquitin-proteasome degradation.\",\n      \"method\": \"Co-immunoprecipitation of Mfn2-Hsc70; electron microscopy of MLC sites; Mfn2 knockdown and overexpression; fatty acid transfer assays; acetylation site mapping; in vivo lipid overload model\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, EM, functional transfer assay, PTM mapping, in vivo model, single lab\",\n      \"pmids\": [\"38311582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Defective Mfn2 variants associated with CMT2A (near HB1-HB2 hinge) show reduced GTP-dependent oligomerization in cis and impaired membrane fusion in vitro; addition of cytosolic extract or soluble Bax improves both nucleotide-dependent assembly and fusion, suggesting cytosolic factors can compensate for molecular defects of CMT2A variants.\",\n      \"method\": \"In vitro membrane fusion assay with reconstituted proteoliposomes; nucleotide-dependent assembly assays; addition of purified Bax or cytosol extract; Mfn2-null cell rescue for morphology\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro fusion assay, GTP assembly assay, defined variant mutagenesis, biochemical rescue\",\n      \"pmids\": [\"32245838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"E3 ubiquitin ligase RBCK1 interacts with and polyubiquitylates MFN2, promoting its proteasomal degradation under ferroptotic stress in pancreatic cancer cells, leading to decreased mitochondrial ROS production and lipid peroxidation, thereby conferring ferroptosis resistance.\",\n      \"method\": \"Co-immunoprecipitation of RBCK1-MFN2; ubiquitylation assays; RBCK1 knockdown/depletion; xenograft mouse model; ROS and lipid peroxidation measurements\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP, ubiquitylation assay, genetic KO, in vivo xenograft, single lab\",\n      \"pmids\": [\"38763208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MFN2 physically interacts with Rab21 (in its GTP-loaded form); through this EGFR-Rab21-MFN2 axis, endocytosed EGFR is docked to mitochondria and dephosphorylated by OMM-resident phosphatase PTPRJ, suppressing EGFR signaling and ccRCC progression.\",\n      \"method\": \"Bio-layer interferometry and Co-immunoprecipitation of MFN2-Rab21; Co-IP of EGFR-Rab21-MFN2; mass spectrometry; kidney-specific Mfn2 knockout mouse model; xenograft assays\",\n      \"journal\": \"Cancer communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — BLI biophysical binding, Co-IP, tissue-specific KO mouse, single lab\",\n      \"pmids\": [\"37378422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mfn2 downregulation in microglia causes mitochondrial fusion-fission imbalance, triggering release of mitochondrial DNA into the cytoplasm, which activates the cGAS-STING signaling pathway and aggravates neuroinflammation after spinal cord injury.\",\n      \"method\": \"Microglial Sting knockout mouse model; Mfn2 siRNA knockdown in microglia; cytosolic mtDNA quantification; cGAS-STING pathway activation assays (TBK1, IRF3 phosphorylation); nanoparticle delivery of MFN2 agonist\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO, siRNA, pathway activation assays, in vivo SCI model, single lab\",\n      \"pmids\": [\"38009491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"E2F1 transcription factor directly binds the MFN2 promoter and increases endogenous MFN2 expression; E2F1 and SP1 form a complex on the MFN2 promoter during S-phase. E2F1-driven MFN2 expression modulates mitochondrial fusion and mitophagy.\",\n      \"method\": \"E2F1 overexpression; chromatin immunoprecipitation (ChIP) for E2F1 and SP1 on MFN2 promoter; Co-IP of E2F1-SP1; MFN2 mRNA and protein measurement; mitophagy and mitochondrial morphology assays\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — ChIP, Co-IP of transcription complex, overexpression, functional mitochondrial readouts, single lab\",\n      \"pmids\": [\"31276298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mfn2 physically interacts with IP3R3 in pulmonary arterial smooth muscle cells; this interaction mediates mitochondrial Ca2+ transport via MAMs. Mfn2 overexpression reduces IP3R3 expression, decreases excessive mitochondrial Ca2+ transport, and restores mitochondrial integrity, suppressing PASMCs proliferation.\",\n      \"method\": \"Co-immunoprecipitation of Mfn2-IP3R3; Mfn2 overexpression and silencing; IP3R3 inhibition; mitochondrial Ca2+ measurements; MCT-induced PAH rat model\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP, genetic OE/KD, Ca2+ assays, in vivo rat model, single lab\",\n      \"pmids\": [\"40128893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP2 (deubiquitinating enzyme) interacts with MFN2 and stabilizes it through deubiquitination, thereby preventing mitochondrial dysfunction in cardiac hypertrophy. MFN2 knockdown neutralizes the protective effect of USP2 overexpression.\",\n      \"method\": \"Co-immunoprecipitation of USP2-MFN2; deubiquitination assay; USP2 overexpression and MFN2 siRNA rescue experiments; in vitro and in vivo cardiac hypertrophy models\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP, deubiquitination assay, rescue experiment, in vivo model, single lab\",\n      \"pmids\": [\"37100191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MORN4 directly binds MFN2 and promotes phosphorylation of MFN2-S442 through ROCK2 kinase, mediating beneficial mitophagy through mitochondrial dynamics. SPC promotes the MORN4-MFN2 interaction.\",\n      \"method\": \"Co-immunoprecipitation of MORN4-MFN2; phospho-MFN2-S442 measurement; ROCK2 kinase assays; MORN4 knockdown mouse MI model; confocal mitophagy assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP, phosphorylation assay, single lab, single study\",\n      \"pmids\": [\"36682578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Mul1 E3 ubiquitin ligase binds MFN2 and promotes its ubiquitination and degradation in the context of cerebral ischemia/reperfusion injury; ginsenoside CK reduces the Mul1-MFN2 binding affinity, thereby preserving MFN2 protein levels and mitochondrial dynamics.\",\n      \"method\": \"Co-immunoprecipitation of Mul1-Mfn2; ubiquitination assay; pharmacological reduction of Mul1-Mfn2 affinity; in vitro OGD/reperfusion and in vivo MCAO/reperfusion models\",\n      \"journal\": \"Journal of ginseng research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP, ubiquitination assay, single lab, single study\",\n      \"pmids\": [\"37252276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MFN2 stabilizes mitochondria-ER contact sites; the R364W-MFN2 CMT2A mutant alters ER-mitochondria association at MAM junctions, predisposes mitochondria to rapid fission upon mild stress, and perturbs inter-organellar calcium homeostasis.\",\n      \"method\": \"Confocal and proximity ligation assays for MAM contacts; mitochondrial Ca2+ and ER Ca2+ measurements; stress-induced fission assays in cells expressing WT vs. R364W-MFN2\",\n      \"journal\": \"Biology of the cell\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — overexpression of disease mutant, proximity assays, Ca2+ measurements, single lab, single study\",\n      \"pmids\": [\"35924634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Endogenous MFN2 interactome (identified by CRISPR-Cas9 HA-tagging) includes RAB5C (endosomal modulator of mitochondrial homeostasis) and SLC27A2 (fatty acid transporter, relevant to autophagy) as novel validated partners, in addition to known ER and mitochondrial partners, with interactors regulated by nutrient deprivation.\",\n      \"method\": \"CRISPR-Cas9 endogenous HA-tagging of MFN2; HA affinity isolation followed by mass spectrometry; validation of RAB5C and SLC27A2 interactions; functional follow-up for autophagy\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — endogenous tagging, mass spectrometry-based interactome with functional validation of specific partners, single lab\",\n      \"pmids\": [\"39675054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A MFN2 missense mutation (D210V) causes multiple mitochondrial DNA deletions in skeletal muscle, establishing that impaired mitochondrial fusion due to MFN2 dysfunction leads to inability to repair stress-induced mitochondrial DNA damage, and that MFN2 is required for mtDNA stability.\",\n      \"method\": \"Genetic identification of MFN2 D210V mutation; detection of multiple mtDNA deletions in patient skeletal muscle; fibroblast mitochondrial network fragmentation and respiratory chain deficiency; mtDNA damage repair assay\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient-derived fibroblasts, mtDNA repair functional assay, clinical genetics, single family study\",\n      \"pmids\": [\"22189565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Mfn2 overexpression promotes ROS-dependent PINK1/Parkin-pathway mitophagy in nucleus pulposus cells, and Mfn2 overexpression protects against oxidative stress-induced autophagic flux impairment, mitochondrial dysfunction, and apoptosis. Autophagy inhibition blocks these protective effects.\",\n      \"method\": \"Mfn2 KD and OE in rat nucleus pulposus cells; PINK1/Parkin pathway assays; autophagic flux assays; chloroquine inhibition; adenoviral Mfn2 injection in rodent disc degeneration model\",\n      \"journal\": \"Osteoarthritis and cartilage\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, OE/KD with pharmacological inhibition, pathway inference without direct reconstitution\",\n      \"pmids\": [\"31926268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Rab26 interacts with MFN2 and affects MFN2 transport to mitochondria; Rab26 deficiency reduces MFN2 levels in mitochondria, decreasing mitochondrial ROS and ATP production and impairing macrophage phagocytosis.\",\n      \"method\": \"Co-immunoprecipitation of Rab26-MFN2; Rab26 knockout macrophages; MFN2 mitochondrial localization assay; MFN2 siRNA; phagocytosis and ROS/ATP measurements; in vivo Rab26 KO ARDS model\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP, genetic KO, subcellular fractionation, functional readouts, in vivo model, single lab\",\n      \"pmids\": [\"37060270\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MFN2 is a dynamin-like GTPase anchored in the outer mitochondrial membrane and ER that promotes mitochondrial fusion through GTP-dependent oligomerization, tethers the ER to mitochondria via trans-interactions with mitochondrial Mfn1/2 to enable Ca2+ transfer and bioenergetic coupling, forms regulated contacts with lipid droplets (via Hsc70), melanosomes, peroxisomes, and the nuclear envelope (to facilitate PDC nuclear import), restrains PERK kinase activity, suppresses Ras-Raf-ERK and mTORC2/Akt signaling, recruits ATAT1 to microtubule contact sites to regulate α-tubulin acetylation and mitochondrial transport, and is itself controlled by PINK1-mediated phosphorylation (Ser378), PGAM5 dephosphorylation, Parkin/MITOL/RBCK1/LRRK2-driven ubiquitination, and USP2/USP30 deubiquitination, with its activity and stability tuned by these post-translational modifications to coordinate mitochondrial dynamics, quality control, calcium homeostasis, and metabolic signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MFN2 is a dynamin-like GTPase that drives mitochondrial fusion and serves as a master organizer of inter-organelle contact sites, coordinating mitochondrial dynamics, calcium homeostasis, quality control, and metabolic signaling [#0, #8]. Together with its paralog MFN1, it is required for mammalian mitochondrial fusion, forming functional homotypic and heterotypic complexes whose loss causes fragmentation and membrane-potential collapse [#0]; fusion proceeds through GTP-dependent cis-oligomerization gated by an intramolecular interaction (Met376/His380–Asp725/Leu727) that is controlled by PINK1 phosphorylation of adjacent Ser378, and that can be pharmacologically activated to rescue CMT2A-mutant defects [#3, #30]. A distinct ER-localized pool of MFN2 tethers ER to mitochondria by trans-interaction with mitochondrial MFN1/2, enabling ER-to-mitochondria Ca2+ transfer that supports bioenergetics and neuritic outgrowth, acting through contact-site machinery including IP3R3-Grp75 and VAPB-PTPIP51 and engaging SERCA2 to balance Ca2+ flux [#8, #9, #6]. Beyond classical MAMs, MFN2 nucleates contacts with lipid droplets via Hsc70 for fatty-acid transfer, with melanosomes, peroxisomes, and the nuclear envelope, where it tethers mitochondria to enable non-canonical nuclear import of the pyruvate dehydrogenase complex [#29, #15, #19, #7]. MFN2 also functions as a signaling brake, repressing PERK kinase activity at the ER, suppressing Ras-Raf-ERK and mTORC2/Akt pathways through domain-specific interactions, and recruiting ATAT1 to mitochondria-microtubule contacts to regulate α-tubulin acetylation and mitochondrial transport [#1, #14, #13, #28]. MFN2 abundance and fusion activity are tightly set by post-translational control: PGAM5 dephosphorylation protects it from degradation, while phosphorylation by PINK1 and LRRK2 and ubiquitination by Parkin, MITOL, RBCK1, and Mul1 (reversed by USP2) couple MFN2 to mitophagy and stress responses [#10, #25, #12, #24, #31, #36]. Mutations in MFN2 cause Charcot-Marie-Tooth type 2A, and a D210V mutation produces multiple mtDNA deletions, establishing that fusion-competent MFN2 is required for mtDNA stability [#3, #41].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established that MFN2, with MFN1, is essential for mammalian mitochondrial fusion and that fusion is protective, defining the gene's core cell-biological function.\",\n      \"evidence\": \"Mfn1/Mfn2 knockout MEFs with morphology imaging, genetic rescue, and reciprocal Co-IP\",\n      \"pmids\": [\"12527753\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the molecular fusion mechanism or GTPase cycle\", \"Did not address non-fusion functions\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linked MFN2 dysfunction to genomic instability of the mitochondrial genome, showing fusion is required to maintain mtDNA integrity.\",\n      \"evidence\": \"Clinical genetics of MFN2 D210V with patient muscle mtDNA deletion analysis and fibroblast repair assays\",\n      \"pmids\": [\"22189565\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single family study\", \"Mechanism connecting fusion loss to deletion accumulation not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified MFN2 as a signaling regulator, not just a structural fusion protein, by showing it represses PERK at the ER and thereby controls ROS and mitochondrial Ca2+.\",\n      \"evidence\": \"Reciprocal Co-IP and siRNA epistasis in MEFs under ER stress with ROS/Ca2+/morphology readouts; later corroborated in podocytes\",\n      \"pmids\": [\"23921556\", \"34988075\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether repression is direct enzymatic inhibition or contact-dependent unclear\", \"Structural basis of MFN2-PERK interaction unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Mapped MFN2 anti-proliferative signaling to distinct domains acting on the Ras-Raf-ERK axis.\",\n      \"evidence\": \"Domain-fragment Co-IP and rescue in KO MEFs and BJAB cells with proliferation assays\",\n      \"pmids\": [\"24081906\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct versus scaffold role in pathway inhibition not separated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extended MFN2-dependent contact sites beyond ER to melanosomes, implicating it in secretory organelle biogenesis.\",\n      \"evidence\": \"Electron tomography of mitochondria-melanosome contacts with knockdown and melanogenesis assays\",\n      \"pmids\": [\"24485836\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular tether at the melanosome interface unidentified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected MFN2 loss to mitochondrial quality control by revealing a compensatory ROS-HIF1α-BNIP3 mitophagy axis in muscle.\",\n      \"evidence\": \"Skeletal muscle-specific Mfn2 KO mice with mitophagy, ROS, and expression profiling\",\n      \"pmids\": [\"27334614\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular trigger of the adaptive pathway not defined\", \"Tissue-specificity of compensation unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined paralog-specific roles for MFN2 in metabolic tissues, tethering mitochondria to lipid droplets via perilipin 1 and suppressing mTORC2/Akt via HR1.\",\n      \"evidence\": \"Adipose-specific KO with Co-IP and respirometry; CRISPR MFN2 KO with domain-mapped mTORC2 Co-IP and xenografts\",\n      \"pmids\": [\"28348166\", \"28176801\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why MFN1 cannot substitute mechanistically unresolved\", \"mTORC2 finding is single lab, Medium confidence\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved the intramolecular conformational switch governing fusion and showed PINK1 phosphorylates Ser378 to control it, enabling small-molecule MFN2 agonists.\",\n      \"evidence\": \"Interface-residue mutagenesis, in vitro PINK1 kinase assays, and agonist treatment in neurons and a CMT2A mouse model\",\n      \"pmids\": [\"29674596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo phospho-occupancy and dynamics of Ser378 not quantified\", \"How agonists distinguish open versus closed states structurally incomplete\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed Parkin-dependent ubiquitination of MFN2 is required for ER-mitochondria tethering, coupling a mitophagy ligase to contact-site function.\",\n      \"evidence\": \"Non-ubiquitinatable MFN2 mutant rescue, Parkin-deficient patient fibroblasts, Co-IP, and Drosophila PD rescue with synthetic linker\",\n      \"pmids\": [\"30219582\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific ubiquitin chain type and topology not defined\", \"How ubiquitination promotes tethering rather than degradation mechanistically unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated in vitro that CMT2A hinge variants impair GTP-dependent cis-oligomerization and fusion, and that cytosolic factors including Bax can compensate.\",\n      \"evidence\": \"Reconstituted proteoliposome fusion and nucleotide-assembly assays with defined variants plus Bax/cytosol addition\",\n      \"pmids\": [\"32245838\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of compensating cytosolic factors beyond Bax unknown\", \"Physiological relevance of Bax rescue in neurons untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placed MFN2 in energy-stress autophagy by showing AMPK directly engages it to drive MAM formation, a paralog-specific role.\",\n      \"evidence\": \"AMPK-MFN2 Co-IP, Mfn2-null rescue MEFs, EM quantification of MAMs, and metabolic assays\",\n      \"pmids\": [\"32249716\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether AMPK phosphorylates MFN2 directly not established\", \"Order of MAM formation versus autophagy induction unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Separated MFN2's ER-localized tethering/bioenergetic function from its mitochondrial fusion function using organelle-targeted constructs.\",\n      \"evidence\": \"ER- versus mitochondria-targeted Mfn2 rescue in KO neurons with Ca2+ transfer, bioenergetics, and neurite assays; in vivo conditional KO with EM and contact-marker Co-IP\",\n      \"pmids\": [\"34296790\", \"34110411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of ER-Mfn2/mito-Mfn1-2 trans-complex not defined\", \"How the two pools are partitioned in cells unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified VCP cofactor UBXN1 as the machinery extracting MFN2 from the OMM during PRKN-dependent mitophagy.\",\n      \"evidence\": \"UBXN1 KO cells, Co-IP, fractionation, and super-resolution imaging of MFN2 blobs with mitophagy flux\",\n      \"pmids\": [\"33966597\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Whether UBXN1 acts on all ubiquitinated MFN2 pools unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established a paralog-distinct requirement for MFN2 in spermatogenesis via dual mitochondrial and ER functions and translational regulation of germ-cell mRNAs.\",\n      \"evidence\": \"Germ-cell conditional KO with organelle-targeted rescue; Co-IP with nuage proteins and MSY2 plus polysome fractionation\",\n      \"pmids\": [\"32330448\", \"33674260\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking ER/mito function to translation unresolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Broadened MFN2's contact-site repertoire to peroxisomes and the nuclear envelope, the latter enabling non-canonical nuclear import of PDC.\",\n      \"evidence\": \"BioID and dominant-negative truncations for peroxisomes; super-resolution imaging, fractionation, NPC blockade, and PDC-lamin A Co-IP for nuclear envelope\",\n      \"pmids\": [\"35523862\", \"35245450\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trans-partner at peroxisome and nuclear envelope interfaces unidentified\", \"Functional consequence of nuclear PDC incompletely defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified MFN2 as a regulator of metabolic enzyme stability and a hub for receptor downregulation through partner-dependent ubiquitination/dephosphorylation at mitochondria.\",\n      \"evidence\": \"PFK1-TRIM21 degradation via MFN2 C-terminus (Co-IP, SPR, metabolomics, vein graft) and EGFR-Rab21-MFN2-PTPRJ axis (BLI, Co-IP, kidney KO, xenografts)\",\n      \"pmids\": [\"35450439\", \"37378422\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality of MFN2 as a degradation adaptor versus context-specific unclear\", \"Each axis is single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Characterized how CMT2A R364W perturbs contact-site stability and shifts the MITOL/DRP1 fission-fusion balance toward hyperfusion.\",\n      \"evidence\": \"MITOL Co-IP with WT versus R364W, DRP1 ubiquitylation/degradation assays, and MAM/Ca2+ measurements\",\n      \"pmids\": [\"34870686\", \"35924634\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"MAM-contact finding is Low confidence, overexpression-based\", \"How a single residue rewires ligase availability mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established phospho-regulation as a master switch on MFN2 stability and fate, with PGAM5 dephosphorylation favoring fusion and LRRK2 phosphorylation driving degradation.\",\n      \"evidence\": \"PGAM5-MFN2 Co-IP with phospho/ubiquitin assays and Drosophila epistasis; LRRK2-MKK4/JNK phospho-Ser27 mapping with KO mice\",\n      \"pmids\": [\"37498743\", \"37633049\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Which phosphosites PGAM5 targets not fully mapped\", \"Integration of competing kinase/phosphatase inputs unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected MFN2-controlled mitochondrial integrity to innate immune and Ca2+ signaling, including cGAS-STING activation upon mtDNA release and SERCA2-tuned Ca2+ in CD8+ T cells.\",\n      \"evidence\": \"Microglial Sting KO and Mfn2 knockdown with cytosolic mtDNA and pathway assays; CD8+ T cell Mfn2 ablation with SERCA2 Co-IP and tumor models\",\n      \"pmids\": [\"38009491\", \"37738362\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct cause of mtDNA leakage from fusion imbalance not pinpointed\", \"Each context single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealed MFN2 control of the microtubule cytoskeleton and refined its endogenous interactome, linking transport and nutrient-responsive partners.\",\n      \"evidence\": \"MFN2-ATAT1 Co-IP with KO and CMT2A mutant live imaging; CRISPR HA-tagged endogenous interactome by MS validating RAB5C and SLC27A2\",\n      \"pmids\": [\"38883841\", \"39675054\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How CMT2A mutants fail to release ATAT1 structurally unknown\", \"Functional roles of newly validated interactors only partly defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many post-translational inputs (PINK1, LRRK2, PGAM5, Parkin/MITOL/RBCK1/Mul1, USP2) and the ER-versus-mitochondrial pools are integrated in real time to set MFN2's choice among fusion, tethering, and degradation remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified quantitative model of competing PTMs on MFN2\", \"Structures of trans-tethering and contact-site complexes lacking\", \"Mechanism partitioning ER versus mitochondrial MFN2 pools unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [3, 30]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [8, 9, 29, 7]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 13, 14]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005741\", \"supporting_discovery_ids\": [0, 17]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 8, 9]},\n      {\"term_id\": \"GO:0005811\", \"supporting_discovery_ids\": [4, 29]},\n      {\"term_id\": \"GO:0005635\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [2, 5, 17]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [1, 20]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [13, 14, 32]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [4, 16, 29]}\n    ],\n    \"complexes\": [\n      \"MFN1-MFN2 fusion complex\",\n      \"ER-mitochondria tether (MAM)\",\n      \"mitochondria-lipid droplet contact (Hsc70)\"\n    ],\n    \"partners\": [\n      \"MFN1\",\n      \"PERK\",\n      \"SERCA2\",\n      \"IP3R3\",\n      \"PFK1\",\n      \"Hsc70\",\n      \"ATAT1\",\n      \"Rab21\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}